SEC Form 10-Q filed by Grana y Montero S.A.A.

11/14/24 4:17:25 PM ET

Military/Government/Technical

Basic Industries

Get the next $GRAM alert in real time by email

gram-20240930

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

__________________

FORM 10-Q

__________________

(Mark One)


☒			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2024


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ____ to _____.

Commission File Number 000-56348

__________________________________________________


(Exact name of registrant as specified in its charter)

___________________________________________________


Delaware						93-2261104
(State or other jurisdiction of incorporation or organization)						(I.R.S. Employer Identification No.)


3165 Red Hill Avenue Costa Mesa, California						92626
(Address of principal executive offices)						(Zip Code)

(949) 252-1908

(Registrant’s telephone number, including area code)

_______________________________

Securities registered pursuant to Section 12(b) of the Act: None

Securities registered pursuant to Section 12(g) of the Act: Common Stock, par value $0.01 per share

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.


Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of November 12, 2024, there were 287,670,922 shares of common stock of the registrant outstanding.

Gold Flora Corporation

Form 10-Q

For the Quarter Ended September 30, 2024

TABLE OF CONTENTS


	PART I	Page
Item 1.	Financial Statements	2
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	27
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	35
Item 4.	Controls and Procedures	36
	PART II
Item 1.	Legal Proceedings	37
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	37
Item 3.	Defaults Upon Senior Securities	37
Item 4.	Mine Safety Disclosures	37
Item 5.	Other Information	37
Item 6.	Exhibits	38

Unless otherwise noted or the context indicates otherwise, in this quarterly report on Form 10-Q (this “Quarterly Report”), references to (i) “Gold Flora Corporation”, the “Resulting Issuer,” the “Company”, "Gold Flora", “GFC”, “we”, “us” and “our”) refer to Gold Flora Corporation, the Delaware corporation resulting from the Business Combination (as defined herein) and (ii) “TPCO” or “The Parent Company” refer to TPCO Holding Corp. and its subsidiaries prior to the Business Combination.

References in this Quarterly Report to the Company’s websites, social media pages or mobile application or third party websites or applications does not constitute incorporation by reference of the information contained at or available through the Company’s websites, social media pages or mobile application or third party websites or applications, and you should not consider such information to be a part of this Quarterly Report.

This Quarterly Report contains references to our trademarks and trade names and to trademarks and trade names belonging to other entities. Solely for convenience, trademarks and trade names referred to in this report may appear without the ® or ™ symbols, but such references are not intended to indicate, in any way, that their respective owners will not assert, to the fullest extent under applicable law, their rights thereto. We do not intend our use or display of other companies’ trademarks or trade names to imply a relationship with, or endorsement or sponsorship of us or our business by, any other companies.

PART I - FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS


Gold Flora Corporation Interim Condensed Consolidated Balance Sheets (Unaudited) (In USD, in thousands, except for share and per share data)


	September 30, 2024		December 31, 2023
Assets
Current assets:
Cash and cash equivalents	$	10,166	$	22,538
Accounts receivable, Net	4,743		1,773
Inventory	18,780		18,372
Current portion of notes receivable	326		459
Assets held for sale	237		362
Indemnification assets	3,194		3,194
Prepaid expenses and other current assets	8,946		6,165
Total current assets	46,392		52,863

Property and equipment, net	37,470		39,166
Finance lease asset	57,433		60,400
Notes receivable, net of current portion	208		208
Intangible assets, net	42,707		46,101
Operating lease right-of-use assets	21,414		23,655
Deposits and other long term assets	4,071		3,973
Total assets	$	209,695	$	226,366

Liabilities
Current liabilities:
Accounts payable and accrued liabilities	$	54,617	$	27,342
Accrued interest	1,372		1,365
Current portion of taxes payable	17,665		14,135
Due to related party	2,005		2,005
Consideration payable	4,128		4,342
Current portion of notes payable	24,084		18,952

Current portion of operating lease liabilities	3,070		2,562
Current portion of finance lease liabilities	3,508		2,990
Liabilities held for sale	151		282
Total current liabilities	110,600		73,975

Notes payable, net of current portion	4,768		9,189
Convertible notes payable	21,803		20,546
Operating lease liabilities, net of current portion	22,718		25,817
Finance lease liabilities, net of current portion	84,001		85,122
Taxes payable, net of current portion	26,277		13,751
Deferred tax liability	2,842		5,150
Security deposits and other long term liabilities	110		64
Total liabilities	$	273,119	$	233,614



Commitments and contingencies

Shareholders' deficit
Shares of common stock, par value $0.01 per share, 450,000,000 shares of common stock authorized 287,644,766 issued and outstanding at September 30, 2024 and 287,478,982 at December 31, 2023	2,876		2,874
Additional paid in capital	100,943		100,577
Accumulated deficit	(167,134)		(110,833)
Total shareholders' deficit attributable to the Company	(63,315)		(7,382)
Non-controlling interest	(109)		134
Total shareholders' deficit	(63,424)		(7,248)
Total liabilities and shareholders' deficit	$	209,695	$	226,366

The accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements.


Gold Flora Corporation Interim Condensed Consolidated Statements of Operations (Unaudited) (In USD, in thousands, except for share and per share data)

	Three Months Ended				Nine Months Ended
	September 30, 2024		September 30, 2023		September 30, 2024		September 30, 2023
Revenues, net	$	32,621	$	31,960	$	96,416	$	62,569
Cost of goods sold	19,138		20,646		65,656		$	43,269
Gross profit	13,483		11,314		30,760		$	19,300

Selling, general, and administrative expenses	23,008		25,617		62,740		$	43,222
Change in fair value of earn out liability	—		—		—		$	4,375
Total operating expenses	23,008		25,617		62,740		$	47,597

Loss from operations	(9,525)		(14,303)		(31,980)		$	(28,297)

Other (income) expense
Notes payable and convertible notes payable interest expense	1,261		3,181		2,831		$	6,329
Finance lease liability interest expense	3,347		3,373		10,082		$	8,549
Other interest expense	—		—		381		$	—
Amortization of debt discount	444		278		800		$	1,495
Loss on extinguishment of debt	—		1,440		—		$	1,440
Gain on bargain purchase	—		(49,026)		—		$	(49,026)
Other (income) expense, net	2,044		(3,316)		6,482		$	(4,918)
Total other (income) expense, net	7,096		(44,070)		20,576		$	(36,131)

Net income (loss) before income taxes	(16,621)		29,767		(52,556)		$	7,834
Income tax expense	(2,265)		(6,807)		(3,988)		$	(8,321)
Net loss	(18,886)		22,960		(56,544)		$	(487)

Net income (loss) attributable to non-controlling interest	(55)		19		(243)		$	(44)
Net income (loss) attributable to Gold Flora Corporation	$	(18,831)	$	22,941	$	(56,301)	$	(443)

Dividend on preferred stock	$	—	$	(31)	$	—	$	(825)
Net loss attributable to Gold Flora Corporation	$	(18,831)	$	22,910	$	(56,301)	$	(1,268)


Net income (loss) per share - Basic	$	(0.07)	$	0.08	$	(0.20)	$	(0.01)
Net income (loss) per share - diluted	$	(0.07)	$	0.08	$	(0.20)	$	(0.01)
Weighted average number of shares outstanding -Basic	287,643,120		273,642,363		287,590,030		154,766,984
Weighted average number of shares outstanding - diluted	287,643,120		300,318,094		287,590,030		154,766,984

The accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements.


Gold Flora Corporation Interim Condensed Consolidated Statements of Changes in Shareholders’ Deficit (Unaudited) (In USD, in thousands, except for share and per share data)

	Shares of Common Stock	Par Value		Additional Paid in Capital		Accumulated Deficit		Total Shareholders' Deficit Attributable to Gold Flora Corporation		Non-controlling Interest		Total Shareholders' Deficit
Balance June 30, 2023	94,341,622	$	943	$	42,800	$	(91,566)	$	(47,823)	$	111	$	(47,712)
Distributions, net	-	-		(7)		-		(7)		-		(7)

Acquisition date true up	1,235,893	12		(12)		-		-		-		-
Exercise of equity rights on prior acquisition	6,776,482	68		(68)		-		-		-		-
Cancellation of common shares	(136,019)	(1)		1		-		-		-		-
Shares Issued for vesting of RSU's, net	1,011	-		-		-		-		-		-
Accrued preferred distribution to members	-	-		-		(31)		(31)		-		(31)
Preferred distribution payable converted to shares	8,937,247	89		8,464		-		8,553		-		8,553
Fair value of shares issued in a business combination	132,811,589	1,328		19,990		-		21,318		-		21,318
Shares issued for conversion of debt	39,166,191	392		27,068		-		27,460		-		27,460
Conversion of broker units	251,858	3		294		-		297		-		297
Shares issued for contingent consideration amendment	1,096,776	11		164		-		175		-		175
Issuance of shares for debt extinguishment	3,808,250	38		571		-		609		-		609
Share-based compensation	-	-		469		-		469		-		469
Net loss	-	-		-		22,941		22,941		19		22,960
Balance September 30, 2023	288,290,900	$	2,883	$	99,734	$	(68,656)	$	33,961	$	130	$	34,091



	Shares of Common Stock	Par Value		Additional Paid in Capital		Accumulated Deficit		Total Shareholders' Deficit Attributable to Gold Flora Corporation		Non-controlling Interest		Total Shareholders' Deficit
Balance June 30, 2024	287,618,418	$	2,876	$	100,855	$	(148,303)	$	(44,572)	$	(54)	$	(44,626)



Shares Issued for Option Exercises, Net	-	-		1		-		1		-		1

Shares Issued for Vesting of RSU's, Net	26,348	-		-		-		-		-		-







Share-Based Compensation	-	-		87		-		87		-		87
Net Loss	-	-		-		(18,831)		(18,831)		(55)		(18,886)
Balance September 30, 2024	287,644,766	$	2,876	$	100,943	$	(167,134)	$	(63,315)	$	(109)	$	(63,424)

The accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements.


Gold Flora Corporation Interim Condensed Consolidated Statements of Changes in Shareholders’ Deficit (Unaudited) (In USD, in thousands, except for share and per share data)

	Shares of Common Stock	Par Value		Additional Paid in Capital		Accumulated Deficit		Total Shareholders' Deficit Attributable to Gold Flora Corporation		Non-controlling Interest		Total Shareholders' Deficit
Balance December 31, 2022	94,797,102	$	948	$	42,687	$	(67,388)	$	(23,753)	$	174	$	(23,579)
Contributions, net	-	-		3		-		3		-		3
Cancellation of common stock related to participation units	(455,480)	(5)		5		-		-		-		-
Acquisition date true up	1,235,893	12		(12)		-		-		-		-
Exercise of equity rights on prior acquisition	6,776,482	68		(68)		-		-		-		-
Cancellation of common shares	(136,019)	(1)		1		-		-		-		-
Shares Issued for vesting of RSU's, net	1,011	-		-		-		-		-		-
Accrued preferred distribution to members	-	-		-		(825)		(825)		-		(825)
Preferred distribution payable converted to shares	8,937,247	89		8,464		-		8,553		-		8,553
Fair value of shares issued in a business combination	132,811,589	1,328		19,990		-		21,318				21,318
Shares issued for conversion of debt	39,166,191	392		27,068		-		27,460		-		27,460
Conversion of broker units	251,858	3		294		-		297		-		297
Shares issued for contingent consideration amendment	1,096,776	11		164		-		175		-		175
Issuance of shares for debt extinguishment	3,808,250	38		571		-		609		-		609
Share-based compensation	-	-		567		-		567		-		567
Net loss	-	-		-		(443)		(443)		(44)		(487)
Balance September 30, 2023	288,290,900	$	2,883	$	99,734	$	(68,656)	$	33,961	$	130	$	34,091




	Shares of Common Stock	Par Value		Additional Paid in Capital		Accumulated Deficit		Total Shareholders' Deficit Attributable to Gold Flora Corporation		Non-controlling Interest		Total Shareholders' Deficit
Balance December 31, 2023	287,478,982	$	2,874	$	100,577	$	(110,833)	$	(7,382)	$	134	$	(7,248)



Shares Issued for Option Exercises, Net	92,500	1		1		-		2		-		2
Cancellation of Common Shares	(10,074)	-		-		-		-		-		-
Shares Issued for Vesting of RSU's, Net	83,358	1		(1)		-		-		-		-







Share-Based Compensation	-	-		366		-		366		-		366
Net Loss	—	—		—		(56,301)		(56,301)		(243)		(56,544)
Balance September 30, 2024	287,644,766	$	2,876	$	100,943	$	(167,134)	$	(63,315)	$	(109)	$	(63,424)

The accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements.


Gold Flora Corporation Interim Condensed Consolidated Statements of Cash Flows (Unaudited) (In USD, in thousands, except for share and per share data)

	Nine Months Ended
	September 30, 2024		September 30, 2023
Operating activities:
Net loss	$	(56,544)	$	(487)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	12,985		10,197
Gain on bargain purchase price	—		(49,026)
Impairment expense	—		—
Legal Settlement	892		—
Loss on extinguishment of debt	—		1,440
Non-cash operating lease expense	(356)		625
Non-cash interest expense on finance leases added to principal	1,087		1,903
Non-cash interest expense on convertible notes payable added to principal	—		—
Gain on forgiveness of convertible debentures	—		(301)
Change in fair value of earnout liability	—		4,375
Deferred income taxes	(2,308)		4,109
Reserve for inventory	760		—
Debt discount amortization	295		18
Debt issue cost amortization	505		1,477
Share-based compensation	366		567
Bad debt expense	707		328
Change in operating assets and liabilities:
Accounts receivable	(3,677)		619
Prepaid expenses and other current assets	(497)		(165)
Deposits and other long term assets	(52)		(39)
Inventory	(1,168)		(1,024)
Accounts payable and accrued liabilities	24,530		(5,636)
Accrued interest and taxes payable	16,689		6,199
Net cash used in operating activities	(5,786)		(24,821)

Investing activities:
Cash received from asset sale	—		—
Receipt of cash from notes receivable	133		48
Issuance of notes receivable	—		(38)
Purchase of property and equipment and construction costs	(2,183)		(764)
Cash received from acquisition	—		55,306
Net cash (provided by) used in investing activities	(2,050)		54,552

Financing activities:
Proceeds from convertible notes, net of issue costs	—		—
Proceeds from exercise of options	2		—
Payment of convertible notes	—		(1,234)


Repayment of notes	(8,634)		(4,696)
Proceeds from notes	5,786		5,000
Principal repayments of finance lease liability	(2,189)		(1,095)
Payment of acquisition payable	—		—
Contributions, net	—		3
Distributions, net	—		—
Payment of earnout liability	—		(2,000)
Proceeds from Lease incentive payments received	499		1,371
Net cash used in financing activities	(4,536)		(2,651)

Net decrease in cash and cash equivalents	(12,372)		27,080
Cash and cash equivalents, beginning of period	22,538		5,217
Cash and cash equivalents, end of period	$	10,166	$	32,297


	Nine Months Ended
	September 30, 2024		September 30, 2023
Supplemental cash flow disclosure:
Cash paid for interest	$	12,200	$	14,112
Cash paid for taxes	$	5,870	$	8,321

Non-cash investing and financing activities:

Obtaining Property and Equipment relating to a Finance Lease Liability	$	—	$	3,383
Obtaining Property and Equipment relating to issuing Liability	$	2,745	$	—
Other current assets reclassed to property and equipment	$	—	$	2,175
Termination of leases	$	649	$	—
Equity issued to offset accrued expense	$	—	$	472

Reclass of equipment deposits to property and equipment	$	—	$	1,044
Conversion of preferred dividends payable to equity	$	—	$	8,553
Recognition of right-of-use assets and lease liabilities for operating leases	$	—	$	2,064
Accretion of dividends payable	$	—	$	825
Shares issued for conversion of debt	$	—	$	27,460
Conversion of earn out liability to notes payable	$	—	$	2,200
Accrued interest added to principle of notes payable	$	840	$	2,348

Debt issued to finance insurance premiums	$	2,284	$	—

The accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements.


Gold Flora Corporation Notes to Interim Condensed Consolidated Financial Statements (Unaudited) (In USD, in thousands, except for share and per share data)

1. NATURE OF OPERATIONS

Gold Flora Corporation, the “Company”, "Gold Flora", and “GFC”, refer to Gold Flora Corporation, a holding company domesticated in the State of Delaware by way of corporate continuance from British Columbia, Canada on July 7, 2023. The Company’s registered office is located at 3165 Red Hill Avenue, Costa Mesa, CA 92626.

Gold Flora, LLC is a California limited liability company that was formed on November 15, 2016 and is a vertically integrated single-state operator that, through various subsidiaries, has cultivation, manufacturing, distribution and retail operations in California. While the nature of its operations is legalized and approved by the State of California, it is considered to be an illegal activity under the Controlled Substances Act of the United States of America (the “CSA”). Accordingly, certain additional risks and uncertainties are present as discussed in the following notes.

On July 7, 2023, the Company consummated a business combination involving TPCO Holding Corp., a publicly traded entity ("TPCO"), Gold Flora, LLC, Stately Capital Corporation, a newly formed British Columbia corporation and Golden Grizzly Bear LLC, which transaction resulted in the combination of TPCO and Gold Flora, LLC, in an all-stock transaction (the “Business Combination”). In connection with the Business Combination, the Company was deemed to be the accounting acquirer and TPCO was the legal acquirer, and for the purpose of facilitating the merger, a new entity, Gold Flora Corporation was formed. Pursuant to the merger, TPCO, Stately Capital Corporation and GFC amalgamated. The surviving amalgamated company was named Gold Flora Corporation and re-domiciled to Delaware, United States and serves as the parent entity for the Gold Flora group of companies.

The Company is a single state operator ("SSO") in California and operates as a vertically integrated, licensed, group of cannabis companies. The Company's long-term strategy is to continue to be one of the leading cannabis companies in California. The strategy is to build on the Company's strong integrated market position to pursue profitable organic and selective strategic opportunities with a focus on sustainable cash flow.

The Company reports its financial accounts and operations in three segments: retail, wholesale, and management. The retail segment consists of the sixteen operating dispensaries in California. The wholesale segment consists of our bulk flower cultivation operations and cannabis products manufacturing which are both sold to third parties. The Company's management segment represents its corporate office and central costs supporting both the retail and wholesale segments.

Certain prior year amounts for short-term and long-term tax payable have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported total assets, total liabilities, or results of operations.

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Preparation and Statement of Compliance

The accompanying interim condensed consolidated financial statements have been prepared on a going concern basis in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and reflect the accounts and operations of the Company and those of the Company’s subsidiaries in which the Company has a controlling financial interest. Investments in entities in which the Company has significant influence, but less than a controlling financial interest, are accounted for using the equity method.

All intercompany transactions and balances have been eliminated in consolidation. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation of the interim condensed consolidated financial position of the Company as of September 30, 2024 and December 31, 2023, the interim condensed consolidated results of operations for three and nine months ended September 30, 2024 and 2023 and cash flows for the nine months ended September 30, 2024 and 2023 have been included.

The accompanying interim condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements (and notes thereto) in our Annual Report on Form 10-K for the year ended December 31, 2023 (the “Annual Report”), as filed with the United States Securities and Exchange Commission (“SEC”) and with the relevant Canadian securities regulatory authorities under its profile on the System for Electronic Document Analysis and Retrieval Plus (“SEDAR+”). Except as noted below, there have been no material changes to the Company’s significant accounting policies and estimates during the three and nine months ended September 30, 2024.

Basis of Measurement

These interim condensed consolidated financial statements have been prepared on the going concern basis, under the historical cost convention, except for certain financial instruments that are measured at fair value as described herein.


Gold Flora Corporation Notes to Interim Condensed Consolidated Financial Statements (Unaudited) (In USD, in thousands, except for share and per share data)

Going Concern

Historically, the Company’s primary source of liquidity has been its operations, capital contributions made by members and debt financing. However, the Company has sustained annual losses since inception and may require additional capital in the future. As of September 30, 2024 and December 31, 2023, the Company had a total shareholders’ deficit of $63,424 and $7,248 and for the three months ended September 30, 2024 and 2023 a net loss attributable to the Company of $18,831 and $22,941, and net cash used in operating activities of $5,786 and $24,821, respectively. Because of these factors, there is substantial doubt about the Company’s ability to continue as a going concern.

As of September 30, 2024 and 2023, the accompanying interim condensed consolidated financial statements have been prepared on a going-concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The accompanying interim condensed consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from uncertainty related to substantial doubt about the Company’s ability to continue as a going concern.

As described in Note 1, the Company consummated a reverse merger with TPCO on July 7, 2023, forming GFC. The Company plans to reduce operating expenses through various strategic initiatives and aggressive cost-cutting measures which the Company believes will allow it to operate for at least the next twelve months. In addition, the Company plans to raise additional financing if needed to help fund operations. However, there can be no assurance that the Company will be successful in achieving its objectives. These interim condensed consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from uncertainty related to substantial doubt about the Company’s ability to continue as a going concern.

Emerging Growth Company

The Company is an “Emerging Growth Company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it has taken advantage of certain exemptions from various reporting requirements that are not applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a Company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.

Revenue Recognition

Revenue is recognized by the Company in accordance with ASU 2014-09, Revenue from Contracts with Customers (Topic 606). Through application of the standard, the Company recognizes revenue to depict the transfer of promised goods or services to the customer in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services.

In order to recognize revenue under ASU 2014-09, the Company applies the following five (5) steps:

a.Identify a customer along with a corresponding contract;

b.Identify the performance obligation(s) in the contract to transfer goods or provide distinct services to a customer;

c.Determine the transaction price the Company expects to be entitled to in exchange for transferring promised goods or services to a customer;

d.Allocate the transaction price to the performance obligation(s) in the contract; and

e.Recognize revenue when or as the Company satisfies the performance obligation(s).

Revenues consist of wholesale and retail operations of cannabis, which are generally recognized at a point in time when control over the goods have been transferred to the customer and is recorded net of sales discounts. Payment is typically due upon transferring the goods to the customer or within a specified time period permitted under the Company’s credit policy.


Gold Flora Corporation Notes to Interim Condensed Consolidated Financial Statements (Unaudited) (In USD, in thousands, except for share and per share data)

Revenue is recognized upon the satisfaction of the performance obligation. The Company satisfies its performance obligation and transfers control upon delivery and acceptance by the customer. Revenues, net, are disaggregated for the period ended September 30, 2024 and 2023 as follows:


	Three Months Ended				Nine Months Ended
	September 30, 2024		September 30, 2023		September 30, 2024		September 30, 2023
Wholesale	$	8,215	$	3,717	$	18,906	$	9,481
Retail	24,406		28,243		77,510		53,088
Total revenues, net	$	32,621	$	31,960	$	96,416	$	62,569

The Company has a customer loyalty program whereby customers are awarded points with in store and online delivery purchases. Once a customer achieves a certain point level, points can be used to pay for the purchase of product, up to a maximum number of points per transaction. Points expire after six months of no activity in a customer’s account.

The Company’s return policy conforms to the Medicinal and Adult-Use Cannabis Regulation and Safety Act (“MAUCRSA”), which was signed into law in September 2017 and creates the general framework for the regulation of commercial medicinal and adult-use cannabis in California. The Company determined that no provision for returns or refunds was necessary at September 30, 2024 and 2023.

Earnings (Loss) Per Share

Basic earnings (loss) per share (“Basic EPS”) is calculated by dividing the net earnings available to shareholders by the weighted average number of shares outstanding during the period. Diluted earnings per shares is calculated using the treasury method of calculating the weighted average number of shares outstanding. The treasury method assumes that outstanding options with an average exercise price below the market price of the underlying units are exercised, and the assumed proceeds are used to repurchase shares of the Company at the average price of the shares for the period. After adjustments as defined in ASC 260, if the Company is in a net loss position, diluted loss per share is the same as basic loss per share when the issuance of shares on the exercise of convertible debentures, warrants, and share options are anti-dilutive.

Recently Issued Accounting Pronouncements Not Yet Adopted

Segment Reporting

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”), which expands reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses that are regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. The Company is evaluating the impact on the consolidated financial statements and expects to adopt this guidance for our fiscal year ending December 31, 2024.

Income Taxes

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”), which enhances income tax disclosures, primarily through changes to the rate reconciliation and disaggregation of income taxes paid. ASU 2023-09 is effective for annual periods beginning after December 15, 2024, with early adoption permitted. The Company is evaluating the impact on the consolidated financial statements and expects to implement the provisions of ASU 2023-09 for our fiscal year ending December 31, 2025.


Gold Flora Corporation Notes to Interim Condensed Consolidated Financial Statements (Unaudited) (In USD, in thousands, except for share and per share data)

Reclassification

For consistency with the current period presentation, there has been a reclassification of certain prior period amounts from current portion of taxes payable to taxes payable, net of current portion with no effect on the reported total assets, total liabilities, or results of operations.

3. INVENTORY


	September 30, 2024		December 31, 2023
Raw materials	$	2,574	$	1,882
Work in progress	10,297		10,928
Finished goods	5,909		5,562
Total inventory	$	18,780	$	18,372

4. PREPAID AND OTHER CURRENT ASSETS


	September 30, 2024		December 31, 2023
Prepaid supplier payments	$	2,355	$	—
Prepaid expenses other	$	1,327	$	1,131

Prepaid insurance	2,483		1,808
Prepaid inventory	—		515
Prepaid deposits	2,781		2,711
Total prepaid expenses and other current assets	$	8,946	$	6,165

5. PROPERTY AND EQUIPMENT


	September 30, 2024		December 31, 2023
Machinery and equipment	$	15,815	$	15,290
IT equipment	3,846		3,753
Vehicles	807		824
Leasehold improvements	35,918		32,902
Furniture and fixtures	971		971
Assets under construction	486		106
Total property and equipment, gross	57,843		53,846
Less: Accumulated depreciation and amortization	(20,373)		(14,680)
Total property and equipment, net	$	37,470	$	39,166

Assets under construction represent construction in progress related to both cultivation, distribution and extraction facilities not yet completed or otherwise not ready for use.

Depreciation and amortization expense for the three and nine months ended September 30, 2024 totaled $2,738 and $6,624, respectively, of which $3,126 and $4,964, respectively, is included in cost of goods sold. Depreciation and amortization expense for the three and nine months ended September 30, 2023 totaled $1,874 and $4,075, respectively, of which $1,056 and $2,455, respectively, is included in cost of goods sold.


Gold Flora Corporation Notes to Interim Condensed Consolidated Financial Statements (Unaudited) (In USD, in thousands, except for share and per share data)

6. INTANGIBLE ASSETS


	September 30, 2024		December 31, 2023
Trade name	$	10,864	$	10,864
Licenses	42,542		42,542
Non-compete	450		450
Total intangible assets, gross	53,856		53,856
Less: Accumulated amortization	(11,149)		(7,755)
Total intangible assets, net	$	42,707	$	46,101

For the three and nine months ended September 30, 2024, amortization expense related to intangible assets totaled $1,140 and $3,394, respectively. For the three and nine months ended September 30, 2023, amortization expense related to intangible assets totaled $2,636 and $4,179, respectively. Additionally, during the period ended September 30, 2024, management noted no indications of impairment on its intangible assets.

7. ACCOUNTS PAYABLE AND ACCRUED LIABILITIES


	September 30, 2024		December 31, 2023
Accounts payable	$	21,185	$	13,339
Accrued payroll and related	2,369		2,588
Accrued purchases	9,593		2,839
Liability to dissenting shareholders	3,047		3,047
Other accrued expenses	18,423		5,529
Total accounts payable and accrued liabilities	$	54,617	$	27,342

8. LEASES

Operating Leases

The Company leases certain business facilities from related parties and third parties under non-cancellable operating lease agreements that specify minimum rentals. The operating leases require monthly payments ranging from $2 to $78 and expire through August 2038. Certain lease monthly payments may escalate up to 5.0% each year. In such cases, the variability in lease payments is included within the current and non-current operating lease liabilities.

All real estate leases are recorded on the balance sheet. Equipment and other non-real estate leases with an initial term of twelve months or less are not recorded on the balance sheet. Lease agreements for some locations provide for rent escalations and renewal options. Certain real estate leases require payment for taxes, insurance and maintenance which are considered non-lease components. The Company accounts for real estate leases and the related fixed non-lease components together as a single component.

The Company determines if an arrangement is a lease at inception. The Company must consider whether the contract conveys the right to control the use of an identified asset. Certain arrangements require significant judgment to determine if an asset is specified in the contract and if the Company directs how and for what purpose the asset is used during the term of the contract.

Finance Leases

The Company has certain finance leases from third parties and related parties as of September 30, 2024 and December 31, 2023 for property in Desert Hot Springs, CA, Long Beach, CA, Commerce, CA, Corona, CA, and certain vehicle finance leases, with up to 30 years terms.


Gold Flora Corporation Notes to Interim Condensed Consolidated Financial Statements (Unaudited) (In USD, in thousands, except for share and per share data)

ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease.


	Three Months Ended				Nine Months Ended
	September 30, 2024		September 30, 2023		September 30, 2024		September 30, 2023
Finance lease cost:
Amortization of finance lease right-of-use assets	$	1,008	$	1,411	$	2,967	$	2,399
Interest on lease liabilities	3,347		3,373		10,082		8,549
Sublease (Income)	(610)		(609)		(1,755)		(1,840)
Operating lease cost	1,536		1,679		4,608		2,861
Total lease expenses	$	5,281	$	5,854	$	15,902	$	11,969


	Nine Months Ended
	September 30, 2024		September 30, 2023
Cash paid for amounts included in the measurement of lease liabilities:
Financing cash flows from finance lease, principal payment	$	2,189	$	1,095
Financing cash flows from finance lease, interest payment	8,982		6,633
Operating cash flows from operating leases, gross	4,881		2,211
Cash received for lease incentive payments	499		1,371
Non-cash additions to right-of-use assets and lease liabilities:
Reduction in lease liability and right-of-use asset due to termination	649		—
Recognition of right-of-use assets for finance lease	—		3,383
Right-of-use assets for finance lease assumed on business acquisition	$	—	$	7,775
Recognition of right-of-use assets for operating leases	$	—	$	2,064
Right-of-use assets for operating leases assumed on business acquisition	$	—	$	12,814

Other information related to operating and finance leases as of and for the nine months ended September 30, 2024 are as follows:


	Nine Months Ended
	September 30, 2024		September 30, 2023
Weighted-average remaining lease term (years) - Finance leases	23.13		23.37
Weighted-average remaining lease term (years) - Operating leases	7.25		7.78
Weighted-average discount Rate - Finance leases	15.63	%	16.00	%
Weighted-average discount rate - Operating leases	14.01	%	14.00	%


Gold Flora Corporation Notes to Interim Condensed Consolidated Financial Statements (Unaudited) (In USD, in thousands, except for share and per share data)

The maturity of the contractual undiscounted lease liabilities as of September 30, 2024:


Year Ending December 31,	Operating Leases		Finance Leases
2024 (Remaining)	$	1,649	$	3,809
2025	6,574		15,366
2026	6,622		15,761
2027	5,633		14,793
2028	4,356		11,178
Thereafter	17,337		337,419
Total future minimum lease payments	42,171		398,326
Less: Interest	(16,383)		(310,817)
Present value of lease liabilities	25,788		87,509
Less: Current portion of lease liabilities	(3,070)		(3,508)
Lease liabilities, net of current portion	$	22,718	$	84,001


Gold Flora Corporation Notes to Interim Condensed Consolidated Financial Statements (Unaudited) (In USD, in thousands, except for share and per share data)

9. NOTES PAYABLE


	Interest rate	Maturity Date	Payment terms	September 30, 2024		December 31, 2023
Shelf Life, Inc. Promissory note - October 1, 20192	—%	December 31, 2022	Due at maturity	$	5,837	$	5,200
J.J. Astor & Co. Promissory Note (Initial Draw) - August 2024	—%	September 11, 2025	53 weekly payments	8,795		—
Acquisition note payable - December 2021	8.0%	December 31, 2025	Twelve quarterly payments of principal and interest beginning in March 2023	5,407		8,196
Equipment loan, secured by substantially all assets of the Company.	9.5% plus the Secured Overnight Financing Rate but not less than 2.99% or more than 5.5% ("SOFR"), plus a service fee of 2.0%	December 14, 2025	Principal and interest of $140 plus the SOFR payment paid monthly, remaining balance due at maturity	1,994		2,712
Acquisition note payable - September 2021	6.0%	September 30, 2025	Twelve quarterly payments of principal and interest beginning in December 2022	4,678		7,545
Promissory note - July 7, 2023	8.0%	July 7, 2027	Twelve quarterly payments of principal and interest beginning in October 2024	2,374		2,200
Short-term insurance financing	8.4%	April 1, 2025	Monthly payments of principal and interest	1,769		1,055
Promissory notes - various1	1.0%	Various	Interest and principal payments due monthly.	1,294		1,293
Other				—		22
Total notes payable				32,148		28,223
Less: Unamortized discount due to imputed interest				(3,296)		(82)
Total notes payable, net of unamortized debt discount				28,852		28,141
Less: Current portion of notes payable				(24,084)		(18,952)
Notes payable, net of current portion				$	4,768	$	9,189

1The Company entered into the Paycheck Protection Program (“PPP”) loans based on information available at the time. The Company has received multiple Civil Investigative Demands from the Department of Justice ("DOJ") with respect to approximately $1.3 million of PPP loans and potential additional penalty. The Company is engaged with the DOJ to determine its repayment obligations with respect to the PPP loans and is evaluating its options with respect to any repayment claims.

Table of Contents


Gold Flora Corporation Notes to Interim Condensed Consolidated Financial Statements (Unaudited) (In USD, in thousands, except for share and per share data)

2The Company was in active litigation with Shelf Life Inc. (“SLI”). There has been an interim judgement granted against Gold Flora for the $5.2 million balance owed on the applicable note. The arbitration was resolved on August 23, 2024 for a final judgment of $6.1 million. For additional information, refer to 14. Commitments and Contingencies – Claims and Litigation.

During the quarter ended September 30, 2024, Gold Flora entered into a Loan Agreement with J.J. Astor & Co. (the "Investor"), pursuant to which, among other things, the Company agreed to issue and sell to the Investor, in exchange for the payment by the Investor of $6.9 million, a senior secured promissory note in an aggregate principal amount of $9.3 million (the “Initial Note”). The Loan Agreement also provides for the future issuance of up to three additional notes (the “Additional Notes”) and together with the Initial Note, subject to certain conditions and on substantially the same terms as the initial closing. Each subsequent closing would result in the issuance of an Additional Note with an original principal amount of $2.8 million and a funded amount of $1.9 million.

The Initial Note is secured by a pledge of the Company’s stock and other equity interests in certain of its subsidiaries pursuant to a pledge agreement between the Company and the Investor, which will constitute a lien and security interest if the Investor accelerates the amount due under the Initial Note or any Additional Note during an event of default. The Initial Note may be prepaid, and the principal amount will be reduced to approximately $8.33 million if prepaid within 30 days of issuance, to approximately $8.55 million if prepaid between 30 and 60 days after issuance, and to approximately $8.84 million if prepaid between 60 and 90 days after issuance.

The Initial Note imposes certain customary affirmative and negative covenants upon the Company, as well as covenants that (i) restrict the Company and its subsidiaries from incurring any additional indebtedness or suffering any liens, subject to specified exceptions, (ii) restrict the issuance or repurchase of shares of the Company’s common stock, subject to specified exceptions, and (iii) restrict the declaration of any dividends or other distributions, subject to specified exceptions. If an event of default under the Initial Note or any Additional Note occurs, the principal amount will be multiplied by 110% and interest will begin accruing at a default rate of 10% per annum from the date of a default. Upon an event of default and following any applicable cure periods, the Investor may elect to accelerate the Initial Note or any Additional Note and thereafter convert all or a portion of the outstanding notes into shares of the Company’s common stock. The conversion price for any such conversion will be equal to 90% of the average of the four lowest volume weighted average closing prices of the Company’s common stock on the Cboe Canada exchange during the 20 trading days prior to the conversion, subject to adjustment in the event of any issuance of securities at a lower purchase, exercise or conversion price, and subject to applicable limitations of the Cboe Canada exchange.

10. CONVERTIBLE NOTES PAYABLE


	September 30, 2024		December 31, 2023
Convertible notes payable	$	22,648	$	21,896
Less: Unamortized discount due to imputed interest	(845)		(1,350)
Total convertible notes payable, net	21,803		20,546

Higher Level of Care and Airfield Financing

On July 6, 2023, prior to the Business Combination, the Company entered into a debt modification with certain convertible debt holders above, representing approximately $22,515 in convertible debt. As consideration for the debt modification and voting support agreement, the Company issued 2,500,000 Class C member units to these convertible debt holders which were ultimately converted to common shares of the Company upon the merger. Management determined the debt modification was considered an extinguishment of debt and recorded a loss on extinguishment of debt in the amount of approximately $1,440. The modified unsecured convertible debt bears interest at 8 percent per annum, matures on December 31, 2025 and is convertible at the option of the debt holders at $0.7549 per share of common stock. The mandatory conversion feature, that was previously contained in the agreements, was removed and replaced with an optional conversion feature, at the Company's discretion, in the event the Company’s common stock exceeds a 20-day volume weighted average price ("VWAP") of $1.0175 per share of common stock. In the event the 20-day VWAP is met, the Company may elect to require that the holders of the convertible debt convert at a price of $0.7549 per share of common stock.


Gold Flora Corporation Notes to Interim Condensed Consolidated Financial Statements (Unaudited) (In USD, in thousands, except for share and per share data)

11. SHAREHOLDERS' EQUITY

Authorized Shares

Prior to the merger, each member’s interest in the Gold Flora LLC, including the member’s interest in income, gains, losses, deductions and expenses of Gold Flora LLC, was represented by units (“LLC Units”), which are further divided by Class from A through F. Upon a liquidation event, LLC Units were generally entitled to their pro-rata portion of net assets based on total equity instruments then outstanding to reduce the holders invested capital to zero and any remaining was shared pro rata share among the member LLC units holders. Gold Flora LLC was authorized to issue unlimited LLC Units.

There was an 8% simple non-compounded return to the holders of Class B Units. Gold Flora LLC had determined it was obligated to pay such amount, and accordingly accrued the return on the basis of outstanding investment amount quarterly.

The Company has total authorized shares of common stock of 450,000,000.

Issued and Outstanding

There were 287,644,766 and 287,478,982 shares of common stock issued and outstanding as of September 30, 2024 and December 31, 2023, respectively.

Equity Incentive Plans

The Company established the Gold Flora Corporation 2023 Equity Incentive Plan ("Gold Flora EIP") for certain qualified officers, employees, consultants and non-employee directors. The Gold Flora EIP establishes award units in various forms as allowed under the plan and is administered by the board of directors of the Company. Total shares reserved under the Gold Flora EIP available for grant and issuance will not exceed 15 percent of the Company's total issued and outstanding shares from time to time or as may be approved in accordance with the Cboe Canada exchange policies. The below is information pertaining to legacy and new awards outstanding.

Share based compensation expense consists of options for the nine months ended September 30, 2024 and profit interest for the nine months ended September 30, 2023. Share based compensation was $366 and $567 during the period ended September 30, 2024 and 2023, respectively. All profit interest units were exchanged to common stock upon the Business Combination and no profit interest units remain outstanding. The Company recognized forfeitures when they occurred.

Restricted Stock Units


	Issued and Outstanding	Weighted Average Grant Date Fair Value
Balance as of December 31, 2023	217,298	$	3.14
Vested and Settled	(101,260)	3.30
Forfeited	(11,281)	3.34
Balance as of September 30, 2024	104,757	$	2.95

Options

Certain options outstanding relate to a legacy option plan from prior acquisitions. No further options will be issued under those legacy plans.


Gold Flora Corporation Notes to Interim Condensed Consolidated Financial Statements (Unaudited) (In USD, in thousands, except for share and per share data)


	Number of Options	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value
Balance as of December 31, 2023	13,948,506	$	0.17	9.85

Expired	(29,995)	0.83
Exercised	(92,500)	0.11
Forfeited	(72,946)	0.14
Balance as of September 30, 2024	13,753,065	$	0.17	9.1	$	—
Vested and Expected to Vest	13,753,065	$	0.17	9.1	$	—
Exercisable	5,626,927	$	0.26	9.06	$	—

The aggregate intrinsic value is calculated as the difference between the Company’s closing stock price on September 30, 2024 and the exercise price of options, multiplied by the number of options. As of September 30, 2024, total unrecognized stock-based compensation was approximately $740, which are expected to be recognized over a weighted-average period of approximately 2.13 years as of September 30, 2024.

The Company recognizes compensation expense for stock option awards on a straight-line basis over the applicable service period of the award. The service period is generally the vesting period. There were no options issued during the nine months ended September 30, 2024.

Warrants


	Warrants	Weighted - Average Exercise Price
Balance as of December 31, 2023	69,701,256	$	6.27

Balance as of September 30, 2024	69,701,256	6.47

As of September 30, 2024 and December 31, 2023, the weighted-average remaining term for the outstanding warrants was 1.2 years and 1.73 years, respectively. No warrants were issued during the nine months ended September 30, 2024.


Gold Flora Corporation Notes to Interim Condensed Consolidated Financial Statements (Unaudited) (In USD, in thousands, except for share and per share data)

12. RELATED PARTY TRANSACTIONS AND BALANCES

Expenses incurred and contributions received from related parties, and amounts due to and (due from) related parties, which are included as components of accounts payable and accrued liabilities or (accounts receivables) in the accompanying interim condensed consolidated balance sheets as of September 30, 2024 and December 31, 2023 and the interim condensed consolidated statements of operations for the period ended September 30, 2024 and 2023 are as follows:


			Incurred (Received)				Due To (From)
Related Party Name	Relationship	Nature of Transactions	September 30, 2024		September 30, 2023		September 30, 2024		December 31, 2023
127 Radio Road Partners, LLC	Co-owned by a shareholder of the Company	Facility Rent	$	356	$	389	$	6	$	6
BlackStar Contractors Inc.	Co-owned by a shareholder of the Company	Construction of Facilities	—		12		1,044		(1,252)
BlackStar Financial Inc.	Co-owned by a shareholder of the Company	Shared Services	16		150		66		50
BlackStar Industrial Properties LLC	Co-owned by a shareholder of the Company	Facility Rent and Advances	—		5		2,644		2,644
GF 5630 Partners LLC	Managed by Directors and officers of Gold Flora Corporation	Facility Rent	433		404		369		290
Gold Flora Capital LLC	Managed by Directors and officers of Gold Flora Corporation	Interest Expense	—		4		16		16
MasterCraft Homes Group LLC	Co-owned by a shareholder of the Company	Shared Services	—		7		81		39


Burr Property Management	Management	Consulting Fees	210		208		40		—
Skyfall Partners LLC	Management	Shared Services	$	—	$	—	$	496	$	—
		Total	$	1,015	$	1,179	$	4,762	$	1,793

In addition, to the above transactions, the Company entered into a promissory note with Skyfall Partners, LLC, an entity majority owned by a shareholder of the Company, dated December 31, 2020, which matured on December 22, 2021 and bears interest at an interest rate of 10% with principal and unpaid interest due at maturity. The balance of the note payable at September 30, 2024 and December 31, 2023 was $425. The note was amended to extend the maturity date to April 2023. The Company is currently in negotiations to extend the maturity date. Amounts due to Skyfall Partners, LLC is included as a component of due to related parties in the accompanying interim condensed consolidated balance sheets.

In addition, to the above transactions, the Company entered into a promissory note with BlackStar Capital Partners, LLC, an entity majority owned by a shareholder of the Company, dated December 15, 2021, which matured on June 14, 2023 and bears interest at an interest rate of 10% with principal and unpaid interest due at maturity. The Company is currently in negotiations to extend the maturity date. The balance of the note payable at September 30, 2024 and December 31, 2023 was both $1,580. Amounts due to Black Star Capital Partners, LLC is included as a component of due to related parties in the accompanying interim condensed consolidated balance sheets.


Gold Flora Corporation Notes to Interim Condensed Consolidated Financial Statements (Unaudited) (In USD, in thousands, except for share and per share data)

13. INCOME TAXES

The following table summarizes the Company’s income tax expense and effective tax rates for the period ended September 30, 2024, and 2023:


	Three Months Ended						Nine Months Ended
	September 30, 2024			September 30, 2023			September 30, 2024			September 30, 2023
Net Income (Loss) Before Income Taxes	$	(16,621)		$	29,767		$	(52,556)		$	7,834
Income Taxes	$	(2,265)		$	(6,807)		$	(3,988)		$	(8,321)
Effective Tax Rate	13.6		%	(22.9		%)	7.6		%	(106.2		%)

For the three and nine months ended September 30, 2024 and 2023, the Company calculated its provision by applying the discrete method due to the inability to rely on forecasts. The Company believes the discrete method to calculate the interim tax provision is more appropriate. For the three and nine months ended September 30, 2024, income tax expense increased as compared to the same periods in the prior year resulting from the Business Combination that occurred on July 7, 2023.

Due to its cannabis operations, the Company is subject to the limitations of Internal Revenue Code (“IRC”) Section 280E. Under IRC Section 280E, the Company is only allowed to deduct expenses directly related to sales of its cannabis products. This results in permanent differences between ordinary and necessary business expenses deemed non-deductible under IRC Section 280E for the Company's expenses related to its plant-touching cannabis operations.

The effective tax rate for the period ended September 30, 2024, varies from the period ended September 30, 2023, primarily due to addition of penalties and interest and the change in nondeductible expenses under IRC Section 280E as a proportion of pre-tax loss during the period and true up to the beginning net deferred tax liability. The Company incurs expenses that are not deductible due to IRC Section 280E limitations which results in significant permanent book-to-tax differences that may not necessarily correlate with pre-tax income or loss.

The Company files income tax returns in the US and various state jurisdictions and is subject to examination of its income tax returns by tax authorities in these jurisdictions who may challenge any representations made on these returns. The statute of limitations for these jurisdictions may remain open for as far back as tax year 2019 to the present.

The Company recognizes the financial statement impact of a tax position only after determining that the relevant tax authority would more-likely-than-not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the financial statements is the largest impact that has a greater than fifty percent likelihood of being realized upon ultimate settlement with the relevant tax authority. The Company’s federal and state income tax returns are subject to examination by income taxing authorities, generally for three years after the returns are filed.

The Company operates in a number of domestic tax jurisdictions and is subject to examination of its income tax returns by tax authorities in these jurisdictions who may challenge any item of those returns. Because tax matters that may be challenged by tax authorities are typically complex, the ultimate outcome of these challenges is uncertain. The Company accounts for uncertain tax positions by recognizing the financial statement effects of a tax position only when, based upon technical merits, it is more-likely-than-not that the position will be sustained upon examination.

The Company evaluates uncertain tax positions on a quarterly basis and adjusts the level of the liability to reflect any subsequent changes in the relevant facts surrounding the uncertain positions. The measurement of the uncertain tax position is based on the largest benefit amount to be realized upon settlement of the matter. If payment ultimately proves to be unnecessary, the reversal of the liabilities would result in tax benefits being recognized in the period when the Company determines the liabilities are no longer necessary. If the Company’s estimate of tax liabilities proves to be less than the ultimate assessment, a further charge to income tax expense may result.

As of September 30, 2024, the Company recorded an uncertain tax liability for uncertain tax positions primarily related to the treatment of certain transactions and deductions under IRC Section 280E based on legal interpretations that challenge the Company’s tax liability under IRC Section 280E. During Q3 of 2024, the Company filed amended tax returns for periods ending 2020 through 2022 to reflect this position. In Q4 of 2024, the Company filed its 2023 tax returns to reflect this position.

Table of Contents


Gold Flora Corporation Notes to Interim Condensed Consolidated Financial Statements (Unaudited) (In USD, in thousands, except for share and per share data)

The Company does not expect any resolution to this uncertain tax position in the next 12 months. An estimate of the range of the possible change cannot be made until these tax matters are further developed or resolved. The following table shows a summary of uncertain tax positions, which are recorded on the balance sheet within "Taxes payable, net of current portion":


	Uncertain Tax Provision
Balance December 31, 2023	$	13,751,000
Interest expense	344,000
Income tax payable	4,668,000
Penalties and interest	1,385,000
Income tax expense	4,959,000
Balance September 30, 2024	$	25,107,000

14. COMMITMENTS AND CONTINGENCIES

Periodically, the Company reviews the status of each significant matter and assesses the potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable, and the amount can be reliably estimated, such amounts are recognized in other liabilities.

Contingent liabilities are measured at management’s best estimate of the expenditure required to settle the obligation at the end of the reporting period and are discounted to present value when the effect is material. The Company performs evaluations to identify onerous contracts and, where applicable, records contingent liabilities for such contracts.

Contingent consideration is measured upon acquisition and is estimated using probability weighting of potential payouts. Subsequent changes in the estimated contingent consideration from the final purchase price allocation are recognized in the Company’s interim condensed consolidated statements of operations.

Contingencies

The Company’s operations are subject to a variety of local and state regulations. Failure to comply with one or more of those regulations could result in fines, restrictions on its operations, or losses of permits that could result in the Company ceasing operations in that specific state or local jurisdiction. While management of the Company believes that the Company is in compliance with applicable local and state regulations at September 30, 2024 and December 31, 2023, cannabis regulations continue to evolve and are subject to differing interpretations. As a result, the Company may be subject to regulatory fines, penalties, or restrictions in the future.

The Company has a loyalty program whereby customers accumulate points through purchases, and the earned points can be used to reduce the price of future purchases. The points do not expire and are recorded as a component of accounts payable and accrued liabilities on the accompanying interim condensed consolidated balance sheets for amounts customers have earned but have not yet used.

In connection with the Business Combination in July 2023, certain TPCO shareholders dissented from the vote and were therefore entitled to the fair value of their common shares of TPCO ("TPCO Shares"). The fair value amount paid by the Company was calculated based on the closing share price of the TPCO Shares of $0.17696 on June 14, 2023 (being the last trading date prior to the date of the meeting of the shareholders of TPCO to approve the Business Combination. The amount was recorded as a component of accounts payable and accrued liabilities in the accompanying interim condensed consolidated balance sheet. Certain of the dissenting TPCO shareholders have asserted that the fair value of their TPCO Shares was higher than the trading price of June 14, 2023 and should have been determined to be at least US$0.9847 per TPCO Share. On September 8, 2023, those certain former TPCO shareholders filed a petition in the Supreme Court of British Columbia to be paid their asserted value per TPCO Share. However, the ultimate amount required to be paid by Gold Flora is subject to determination by the Supreme Court of British Columbia. The determination hearing is expected to occur in the fourth quarter of 2024, with a final judgement expected to be issued in due course thereafter.

Claims and Litigation

From time to time, the Company may be involved in litigation relating to claims arising out of operations in the normal course of business.


Gold Flora Corporation Notes to Interim Condensed Consolidated Financial Statements (Unaudited) (In USD, in thousands, except for share and per share data)

On or about August 30, 2020, Gold Flora parties filed an action against SLI in Orange County Superior Court in California, which actions was later submitted to binding arbitration pursuant to stipulation by the parties. In the action, Gold Flora disputed the amount of closing consideration owed to SLI following the acquisition of certain of its assets based on omission of relevant information, and SLI brought a cross-claim against Gold Flora seeking full payment of the $5.2 million note balance owed. The arbitrator in the matter issued an interim judgement awarding SLI $5.2 million, in addition to certain potential costs and interest. The arbitration was resolved on August 23, 2024 for a final judgment is for $6.1 million. The incremental amount was since added to the Shelf-Life note as disclosed in the notes payable footnote.

On or about October 28, 2022, Jeff and Shanna Droege filed a Notice of Arbitration alleging breach of contract and other business torts against Left Coast Ventures ("LCV") and three former LCV directors in front of JAMS Resolution Center in San Francisco. Subsequently, the claims against the indemnified LCV directors were moved to a separate action filed in the Superior Court of California, Santa Clara, which claims against two of the directors have now been dismissed with prejudice. Monetary relief is sought in each outstanding action. The arbitration decision is expected in the fourth quarter of 2024.

On or about March 30, 2021, former directors and shareholders of LCV filed a complaint in Delaware Chancery Court against multiple defendant parties, including three former directors of LCV, alleging breach of duties to the company and shareholders and other business torts and requesting monetary damages. Subsequently, plaintiffs filed a first amended complaint, adding new parties, including TPCO and a former TPCO director. LCV and the Company have certain indemnification obligations in connection with the defendant directors, which indemnification may be contested by LCV upon resolution of the action. The Company and LCV are subject to advancement actions brought with fees owed or claimed to be owed to counsel for the indemnified defendants.

15. FINANCIAL INSTRUMENTS

Credit Risk

Credit risk arises from deposits with banks, accounts receivable, security deposits and notes receivable. The balances were as follows as of:


	Gross as of September 30, 2024		Allowance		Net as of September 30, 2024
Cash and cash equivalents	$	10,166	$	—	$	10,166
Accounts receivable	5,395		(652)		4,743
Deposits and other long term assets	4,071		—		4,071
Notes receivables	534		—		534
Total	$	20,166	$	(652)	$	19,514


	Gross as of December 31, 2023		Allowance		Net as of December 31, 2023
Cash and cash equivalents	$	22,538	$	—	$	22,538
Accounts receivable	2,009		(236)		1,773
Deposits and other long term assets	3,973		—		3,973
Notes receivables	667		—		667
Total	$	29,187	$	(236)	$	28,951


Gold Flora Corporation Notes to Interim Condensed Consolidated Financial Statements (Unaudited) (In USD, in thousands, except for share and per share data)

16. SEGMENT REPORTING

The Company operates in three segments: wholesale, retail, and management. The below table presents financial information by type as of and for the years ended:



					September 30, 2024		December 31, 2023
Total assets
Wholesale					$	57,696	$	61,115
Retail					46,569		71,098
Management					105,430		93,926
Intercompany					—		227
Total assets					$	209,695	$	226,366



	Three Months Ended				Nine Months Ended
	September 30, 2024		September 30, 2023		September 30, 2024		September 30, 2023
Revenues, net
Wholesale	$	8,215	$	3,717	$	18,906	$	9,481
Retail	24,406		28,243		77,510		53,088
Total revenues, net	$	32,621	$	31,960	$	96,416	$	62,569

	Three Months Ended				Nine Months Ended
	September 30, 2024		September 30, 2023		September 30, 2024		September 30, 2023
Depreciation and amortization expense
Wholesale	$	3,275	$	2,024	$	7,181	$	4,153
Retail	330		783		1,922		1,721
Management	1,281		2,658		3,882		4,323
Total depreciation and amortization expense	$	4,886	$	5,465	$	12,985	$	10,197

	Three Months Ended				Nine Months Ended
	September 30, 2024		September 30, 2023		September 30, 2024		September 30, 2023
Interest expense
Wholesale	$	2,569	$	719	$	7,369	$	1,107
Retail	617		310		1,672		698
Management	1,866		5,803		5,053		14,568
Total interest expense	$	5,052	$	6,832	$	14,094	$	16,373


Gold Flora Corporation Notes to Interim Condensed Consolidated Financial Statements (Unaudited) (In USD, in thousands, except for share and per share data)




	Three Months Ended				Nine Months Ended
	September 30, 2024		September 30, 2023		September 30, 2024		September 30, 2023
Income tax expense
Retail	—		54		—		$	1,568
Management	2,265		6,753		3,988		6,753
Total income tax expense	$	2,265	$	6,807	$	3,988	$	8,321

17. OPERATING EXPENSES


	Three Months Ended				Nine Months Ended
	September 30, 2024		September 30, 2023		September 30, 2024		September 30, 2023
General and administrative	$	11,228	$	12,978	$	24,919	$	23,269
Allowance for accounts receivable and notes receivable	296		4		707		328
Sales and marketing	1,098		1,151		2,782		1,738
Salaries and benefits	7,003		5,883		21,337		8,660
Share-based compensation	87		469		366		567
Lease expense	1,536		1,678		4,608		2,861
Depreciation of property and equipment and amortization of right-of-use assets under finance leases	620		818		4,627		1,620
Amortization of intangible expenses	1,140		2,636		3,394		4,179
Total selling, general and administrative expenses	$	23,008	$	25,617	$	62,740	$	43,222


Gold Flora Corporation Notes to Interim Condensed Consolidated Financial Statements (Unaudited) (In USD, in thousands, except for share and per share data)

18. LOSS PER SHARE


	Three Months Ended				Nine Months Ended
	September 30, 2024		September 30, 2023		September 30, 2024		September 30, 2023
Net income (loss) attributable to Gold Flora Corporation	$	(18,831)	$	22,941	$	(56,301)	$	(443)
Dividend on preferred stock	—		(31)		—		(825)
Net income (loss) attributable to Gold Flora Corporation	$	(18,831)	$	22,910	$	(56,301)	$	(1,268)

Weighted average number of shares outstanding - basic	287,643,120		273,642,363		287,590,030		154,766,984
Weighted average number of shares outstanding - diluted	287,643,120		300,318,094		287,590,030		154,766,984

Net income (loss) per share - basic	$	(0.07)	$	0.08	$	(0.20)	$	(0.01)
Net income (loss) per share - diluted	$	(0.07)	$	0.08	$	(0.20)	$	(0.01)

Approximately 105,434,265 of potentially dilutive securities at September 30, 2024 were excluded in the calculation of diluted loss per share as their impact would have been anti-dilutive.

19. SUBSEQUENT EVENTS

Receivership

On October 4, 2024, the Court of Chancery of the State of Delaware (the “Court”) granted an order advancing a motion for sanctions brought by former directors of LCV and TPCO (the “Order”) in Michael Auerbach v. Gold Flora Corporation (C.A. No. 2024-0225-MTZ) and Daniel Fireman, Christopher Akelman, Octavio Boccalandra v. Left Coast Ventures, Inc. (C.A. No. 2023-0588-MTZ). The Order held the Company and LCV in contempt for violation of advancement orders with respect to indemnification obligations for fees owed to counsel and related expenses, which amount is currently estimated at approximately $1.65 million.

Pursuant to the Order, the Court appointed Molly DiBianca of Clark Hill PLC (the “Limited Receiver”) as a limited purpose receiver to take such action that the Limited Receiver determines in good faith is appropriate to cause the Company and LCV to satisfy the amounts due under the Order, including accessing financial records and negotiation of a payment plan with the former directors (the “Charge”) pursuant to Title 8, Section 322 of the Delaware General Corporation Law (“Section 322”). The Order did not create a full, general receivership over the Company, and the Limited Receiver’s appointment is limited to the foregoing Charge. The Order provides that the Limited Receiver should first attempt to resort to resolving the Charge through operating cash flow. The Limited Receiver will have all powers generally available to a receiver under Section 322 solely with respect to the Charge, and the Limited Receiver will not have authority over the Company except in connection with the Charge. The initial term for the Limited Receiver was 59 days from the date of the Order. Additionally, Gold Flora and LCV would incur a daily fine of $1,000 until the contempt is cured, provided that the fine would not become due and payable if the Charge is satisfied or a payment plan is in place by October 31, 2024.

On November 4, 2024, the Court issued a stipulation and order (the “Stipulation”) and the Limited Receiver filed an interim report (the “Report”). The Stipulation requires the Company to pay an aggregate of $150,000 per month to the satisfy amounts due under the Order. Pursuant to the Report, the Limited Receiver stayed the limited receivership, conditioned upon the Company’s compliance with the payment plan and satisfaction of any future advancement demands brought by the former directors.


Gold Flora Corporation Notes to Interim Condensed Consolidated Financial Statements (Unaudited) (In USD, in thousands, except for share and per share data)

Additional Note

On November 6, 2024, the Company issued an Additional Note to the Investor pursuant to the Loan Agreement . The Additional Note has an original principal amount of $2.78 million and a funded amount of $1.9 million.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

This Quarterly Report on Form 10-Q (“Form 10-Q”) contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation, that involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Forward-looking statements can be identified by words such as “future,” “anticipate,” “believe,” “estimate,” “expect,” “intend,” “plan,” “will,” “would,” “could,” “can,” “may,” and similar terms. Forward-looking statements are not guarantees of future performance and our actual results may differ significantly from the results discussed in the forward-looking statements. Factors that might cause such differences include, but are not limited to, those discussed in Part I, Item 1A of the Form 10-K for our fiscal year ended December 31, 2023 (the "2023 Form 10-K") under the heading “Risk Factors.” We assume no obligation to revise or update any forward-looking statements for any reason, except as required by law.

Unless otherwise stated, all information presented herein is based on our fiscal calendar, and references to particular years, quarters, months or periods refer to our fiscal years ended on the last day in December and the associated quarters, months and periods of those fiscal years.

The following discussion should be read in conjunction with the 2023 Form 10-K filed with the U.S. Securities and Exchange Commission (the “SEC”) and the unaudited interim condensed consolidated financial statements and accompanying notes included in Part I, Item 1 of this Form 10-Q.

Introduction

This Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) should be read together with other information, including our unaudited interim condensed consolidated financial statements and the related notes to those statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q (the “Interim Financial Statements”). The Interim Financial Statements referenced in this MD&A are prepared in accordance with U.S. GAAP and presented in United States dollars (“$” or “US$”) and expressed in thousands, unless otherwise indicated. Capitalized terms used and not otherwise defined in this MD&A have the meanings given to them in the Interim Financial Statements.

We are an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and we may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non- emerging growth companies but any such election to opt out is irrevocable. We have elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, we, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of our financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

We will remain an emerging growth company until the earlier of (1) the last day of our fiscal year following the fifth anniversary of the date of the first sale of our common equity securities pursuant to an effective registration statement under the Securities Act, (2) the last day of the fiscal year in which we have total annual gross revenue of at least $1.07 billion, (3) the last day of the fiscal year in which we are deemed to be a “large accelerated filer,” as defined in Rule 12b-2 under the Exchange Act, and (4) the date on which we have, during the previous three year period, issued more than $1.0 billion in nonconvertible notes payable.

Gold Flora Corporation is a holding company domesticated in the State of Delaware by way of corporate continuance from British Columbia, Canada on July 7, 2023. Our registered office is located at 3165 Red Hill Avenue, Costa Mesa, CA 92626. Gold Flora, LLC, a wholly owned subsidiary of GFC, is a California limited liability company that was formed on November 15, 2016.

On July 7, 2023, we consummated the Business Combination transaction involving TPCO Holding Corp. ("TPCO"), Gold Flora, LLC, Stately Capital Corporation ("Stately"), a newly formed British Columbia corporation ("Newco"), and Golden Grizzly Bear LLC ("US Merger Sub"), resulting in the combination of TPCO and Gold Flora, LLC, in an all-stock transaction. As part of the Business Combination: (i) TPCO, Stately and Newco amalgamated to form a new corporation (the "Resulting Issuer") and all the shares in the capital of TPCO, Newco and Stately outstanding immediately prior to the amalgamation were cancelled in exchange for common shares in the capital of the Resulting Issuer pursuant to a court approved plan of arrangement under the Business Corporations Act (British Columbia); and (ii) the Resulting Issuer acquired all the issued and outstanding membership units of Gold Flora, LLC by way of a merger

involving US Merger Sub and Gold Flora, LLC. As part of the Business Combination, the Resulting Issuer continued out of British Columbia, Canada and re-domiciled to Delaware, United States pursuant to Section 388 of the Delaware General Corporation Law under the name “Gold Flora Corporation”. Gold Flora Corporation serves as the parent entity for the Gold Flora group of companies.

We are a reporting issuer in each of the provinces and territories of Canada, except Quebec, and in the United States. Our common stock is listed on Cboe Canada under the ticker symbol "GRAM", and our common stock purchase warrants are listed on Cboe Canada under the ticker symbol "GRAM.WT.U". The common stock is also trade-over-the counter in the United States and is quoted on the OTCQB Market operated by OTC Markets Group Inc. under the trading symbol “GRAM”, and the common stock purchase warrants trade on the OTC Pink Market operated by OTC Markets Group Inc. under the trading symbol “GRMW”.

Business Overview

As a result of the Business Combination completed on July 7, 2023, the prior year's results are not directly comparable to our current year results due to the increased operations from the combination of the two companies on a prospective basis starting in July 2023. The prior year's results of operations do not include the operations of TPCO Holding Corp. from January 1, 2023 through July 7, 2023.

We are a single state operator ("SSO") in California and operates as a vertically integrated, licensed, group of cannabis companies. Our operations consist of:

•Cultivation: operated through our wholly-owned subsidiary, Black Lion Farms, LLC ("BLF"), BLF operates an approximately 200,000 square foot facility at the Desert Hot Springs campus ("DHS Campus") dedicated to indoor cultivation, which includes 62,000 square feet of canopy. We have an additional 10,000 square feet of canopy at our San Jose Airfield location and 35,000 square feet of canopy at our San Jose, Caliva facility which also has cultivation operations. The Company is also in the process of adding an additional 53,000 square feet of canopy, bringing the total to 160,000 square feet of indoor grow.

•Manufacturing: operated through our wholly-owned subsidiary, Black Lion Labs, LLC ("BLL"), BLL operates a 10,000 square foot facility at the DHS Campus dedicated to manufacturing. In addition, the Company has an additional 7,000 square feet of space at the DHS Campus through a management service agreement.

•Distribution: operated through our majority held subsidiary, GF Distribution, LLC d/b/a Stately Distribution ("GFD"), GFD operates a California statewide distribution network with three core hubs in Desert Hot Springs, California, Costa Mesa, California and San Jose, California.

•Retail: operated through a number of our wholly-owned subsidiaries, we operate 16 dispensaries in California. We anticipate opening a 17th dispensary in Costa Mesa in the first half of 2025.

Highlights for the Three Months Ended September 30, 2024

Development and Expansion of Gramlin Product Brand

We developed a new, disruptive product brand, Gramlin, designed to appeal to high-volume consumers that frequently purchase flower, vape and pre-roll products. Gramlin was successfully launched in March 2024 through our first party retail outlets and Stately Distribution across California. Gramlin features proprietary genetic strains grown at Gold Flora’s recently expanded cultivation capacity and is strategically priced to offer an unmatchable quality to price ratio, leveraging the competitive advantages provided by our vertical footprint.

Gramlin products are now available across our 16 retail stores, through our commerce digital sites as well as more than 353 third-party retailers across the state through Stately Distribution. Since its initial launch in March 2024, Gramlin has become the second fastest growing brand in California. Gramlin is currently sold in 100% of the top 20 cannabis chain accounts in California.

During the quarter ended September 30, 2024, we added an all in one live rosin vape to the Gramlin line and are now selling to over 150 customer accounts within the first 60 days of launch.

Restructuring Activities

We have diligently and successfully accomplished targeted measures to streamline and integrate legacy operations into our vertically-integrated platform. In addition, we have nearly eliminated reliance on third-party vendors for biomass, manufacturing, and distribution.

Company-Owned Branded Product Growth

Having completed the Business Combination and also much of the cost and retail rationalization, we now benefit from a retail presence that contributes to knowledgeable expansion of company-owned branded product that now includes Aviation Cannabis, Cruisers, Current, Gold Flora, Gramlin, Jetfuel Cannabis, Mirayo by Santana, Monogram and Roll Bleezy. The availability of owned down-stream retail outlets has been instrumental in developing and launching new owned brands such as Gramlin. This enables us to be "quick to market" and nimble in responding to market trends.

Cultivation

Our cultivation capacity is now maximized at the DHS Campus and San Jose campus. Annual flower production is around 40,000 pounds when all flower rooms are operating optimally.

A majority of this flower will be utilized to produce our first party branded packaged products for sale in our retail stores and to third party stores through distribution. This represents a significant increase in capacity dedicated to fulfilling first party product demand internally improving consolidated margins and lowering risk. Excess flower outside of our Consumer Packaged Goods ("CPG") sales channels is being sold through our bulk flower sales team.

During the period ended September 30, 2024, Gold Flora has continued to improve its production performance, with a 20% production increase since the first quarter of 2024, reflecting higher yields and scheduling efficiencies.

Manufacturing

We have centralized our manufacturing at the DHS Campus and over 200 SKUs move through the operation on a monthly basis. Over the past quarter, Gold Flora Manufacturing has focused on two key productivity and margin-drivers that reinforce our vision of vertical integration and scale in the California market:

•Operational efficiencies through automation

•New product commercialization of Gramlin All-in-One Vapes, Infused Pre-Rolls, and Live Rosin Products

Gold Flora has significantly improved operational efficiencies through the maximization of its flower bagging and jarring automated lines. The results of these efforts have enabled production to increase 70% since last quarter.

Distribution Sales

We have strategically increased the number of third party dispensary accounts buying from Stately Distribution contributing to better overall product management and successful brand launches. The expansion was accomplished by the hiring of more experienced sales professionals, a net 50% increase to the total number of sales representatives in the field and an increase in product availability and selection due to the efficiencies achieved following the Business Combination. This has led to our enhanced market position which resulted in an increased demand of our products.

Retail Sales

With the addition of retail locations from the Business Combination, we have expanded our retail footprint and enhanced our market position for Gold Flora owned branded products increasing its first party product revenue generated at its owned retail stores to 34% of total retail store sales in the quarter ended September 30, 2024.

Results of Operations


	Three Months Ended				Nine Months Ended
	September 30, 2024		September 30, 2023		September 30, 2024		September 30, 2023
Revenues, net	$	32,621	$	31,960	$	96,416	$	62,569
Cost of goods sold	19,138		20,646		65,656		43,269
Gross profit	$	13,483	$	11,314	$	30,760	$	19,300

Selling, general, and administrative expenses	23,008		25,617		62,740		43,222

Change in fair value of earn out liability	—		—		—		4,375
Total operating expenses	$	23,008	$	25,617	$	62,740	$	47,597

Loss from operations	(9,525)		(14,303)		(31,980)		(28,297)

Other (income) expense
Notes payable and convertible notes payable interest expense	1,261		3,181		2,831		6,329
Finance lease liability interest expense	3,347		3,373		10,082		8,549
Other interest expense	—		—		381		—
Amortization of debt discount	444		278		800		1,495
Loss on extinguishment of debt	—		1,440		—		1,440
Gain on bargain purchase	—		(49,026)		—		(49,026)
Other (income) expense, net	2,044		(3,316)		6,482		(4,918)
Total other (income) expense, net	$	7,096	$	(44,070)	$	20,576	$	(36,131)

Net income (loss) before income taxes	(16,621)		29,767		(52,556)		7,834
Income tax expense	(2,265)		(6,807)		(3,988)		(8,321)
Net loss	$	(18,886)	$	22,960	$	(56,544)	$	(487)

Net income (loss) attributable to non-controlling interest	(55)		19		(243)		(44)
Net income (loss) attributable to Gold Flora Corporation	$	(18,831)	$	22,941	$	(56,301)	$	(443)

Dividend on preferred stock	—		(31)		—		(825)
Net loss attributable to Gold Flora Corporation	$	(18,831)	$	22,910	$	(56,301)	$	(1,268)

Sales Revenue


	Three Months Ended				Change
	September 30, 2024		September 30, 2023		Amount		%
Wholesale	$	8,215	$	3,717	$	4,498	121.0	%
Retail	24,406		28,243		(3,837)		(13.6)	%
Total revenues, net	$	32,621	$	31,960	$	661


	Nine Months Ended				Change
	September 30, 2024		September 30, 2023		Amount		%
Wholesale	$	18,906	$	9,481	$	9,425	99.4	%
Retail	77,510		53,088		24,422		46.0	%
Total revenues, net	$	96,416	$	62,569	$	33,847

The increase in wholesale revenues for both the three and nine months ended September 30, 2024 is due to increased sales to third party dispensaries driven by the launch of the Gramlin brand during the second quarter of 2024. Gramlin is currently ranked 11th in overall retail sales in California according to Headset.

The decrease in retail revenues for the three months ended September 30, 2024 is attributable to the closure of various non-profitable retail and delivery services during the third quarter of 2023.

The increase in retail revenues for the nine months ended September 30, 2024 is primarily due to the July 2023 Business Combination which added 11 additional retail locations rather than same store sales growth. As of September 30, 2024, we operated 16 retail locations.

Gross Profit


	Three Months Ended						Nine Months Ended
	September 30, 2024			September 30, 2023			September 30, 2024			September 30, 2023
Revenues	$	32,621		$	31,960		$	96,416		$	62,569
Cost of Goods Sold	19,138			20,646			65,656			43,269
Gross Profit	$	13,483		$	11,314		$	30,760		$	19,300
Gross Profit %	41.3		%	35.4		%	31.9		%	30.8		%

Adjustments to Gross profit
Depreciation and Amortization	$	3,126		$	1,056		$	4,964		$	2,455
Operating Expenses Related to 280E Adjustments	4,369			5,717			15,211			8,252
Non-Recurring Inventory Adjustments	125			—			5,742			597
Adjusted Gross Profit	$	21,103		$	18,087		$	56,677		$	30,604
Adjusted Gross Profit %	64.7		%	56.6		%	58.8		%	48.9		%

Gross Profit reflects our revenue less our cost of sales, which consist of costs primarily consisting of labor, materials, consumable supplies, overhead, amortization of production equipment, shipping, packaging and other expenses.

The significant improvement in adjusted gross profit for both the three and nine months ended September 30, 2024 is primarily due to larger scale operations following the Business Combination along with vertical integration efficiencies, bringing distribution in-house, and reduction of third party costs through supply chain optimization. Since the Business Combination, retail has focused on centralizing resources to increase proficiencies in operations and in store profitability and closing non-profitable delivery services. Adjusted Gross Profit is a non-GAAP measure and does not have a standardized meaning prescribed by GAAP. As a result, this measure may not be comparable to similar measures presented by other companies.

Operating Expenses

Selling, General and Administrative Expenses


	Three Months Ended				Change
	September 30, 2024		September 30, 2023		Amount		%
General and administrative	$	11,228	$	12,978	$	(1,750)	(13.5)	%
Allowance for accounts receivable and notes receivable	296		4		$	292	7300.0	%
Sales and marketing	1,098		1,151		$	(53)	(4.6)	%
Salaries and benefits	7,003		5,883		$	1,120	19.0	%
Share-based compensation	87		469		$	(382)	(81.4)	%
Lease expense	1,536		1,678		$	(142)	(8.5)	%
Depreciation of property and equipment and amortization of right-of-use assets under finance leases	620		818		$	(198)	(24.2)	%
Amortization of intangible expenses	1,140		2,636		$	(1,496)	(56.8)	%
Total selling, general and administrative expenses	$	23,008	$	25,617	$	(2,609)	(10.2)	%

The decrease in general administrative expenses for the three months ended September 30, 2024 is primarily due to efficiencies achieved as part of integration since the Business Combination.

The increase in salaries and benefits for the three months ended September 30, 2024 represents additional compensation costs consolidated commencing with the Business Combination. The combined company has a significantly larger retail footprint and related additional operating compensation costs. Prior to the acquisition, Gold Flora, LLC as a cultivation and retail focused private company had smaller cultivation and retail operations.

Depreciation of property and equipment is a non-cash expense and the decrease for the three months ended September 30, 2024 represents the lower property, plant and equipment asset base owned by us at September 30, 2024 compared to September 30, 2023 as a result of the integration efforts since the Business Combination.

Amortization of intangible assets is a non-cash expense. The decrease in amortization expense for the three months ended September 30, 2024 is due to reduction in intangible assets due to amortization.


	Nine Months Ended				Change
	September 30, 2024		September 30, 2023		Amount		%
General and administrative	$	24,919	$	23,269	$	1,650	7.1	%
Allowance for accounts receivable and notes receivable	707		328		379		115.5	%
Sales and marketing	2,782		1,738		1,044		60.1	%
Salaries and benefits	21,337		8,660		12,677		146.4	%
Share-based compensation	366		567		(201)		(35.4)	%
Lease expense	4,608		2,861		1,747		61.1	%
Depreciation of property and equipment and amortization of right-of-use assets under finance leases	4,627		1,620		3,007		185.6	%
Amortization of intangible expenses	3,394		4,179		(785)		(18.8)	%
Total selling, general and administrative expenses	$	62,740	$	43,222	$	19,518	45.2	%

The increase in sales and marketing costs for the nine months ended September 30, 2024 reflects the more retail focus of the business following the Business Combination.

The increase in salaries and benefits for the nine months ended September 30, 2024 represents additional compensation costs consolidated commencing with the Business Combination. The combined company has a significantly larger retail footprint and related additional operating compensation costs. Prior to the acquisition, Gold Flora, LLC as a cultivation and retail focused private company had smaller cultivation and retail operations.

The increase in lease expense for the nine months ended September 30, 2024 was primarily due to the Business Combination resulting in an increase of eleven retail locations.

Depreciation of property & equipment is a non-cash expense and the increase for the nine months ended September 30, 2024 represents the higher property, plant and equipment asset base owned by us at September 30, 2024 compared to September 30, 2023 due to the Business Combination which brought in eleven retail locations.

Amortization of intangible assets is a non-cash expense. The decrease in amortization expense for the nine months ended September 30, 2024 due to reduction in intangible assets due to amortization.

Non-Operating Expenses


	Three Months Ended				Nine Months Ended
	September 30, 2024		September 30, 2023		September 30, 2024		September 30, 2023












Notes payable and convertible notes payable interest expense	$	1,261	$	3,181	$	2,831	$	6,329
Finance lease liability interest expense	3,347		3,373		10,082		8,549
Other interest expense	—		—		381		—
Amortization of debt discount	444		278		800		1,495


Other (income) expense, net	2,044		(3,316)		6,482		(4,918)



Income tax expense	$	(2,265)	$	(6,807)	$	(3,988)	$	(8,321)

Debt and Convertible Debt Interest Expense, Net

The reduction in interest expense for both the three and nine months ended September 30, 2024 is a function of the extinguishment of notes payable and the conversion of debt in July 2023 offset in part by higher rates on the modified convertible debt amended in July 2023 along with the additional interest expense associated with the new promissory note that was entered into during August 2024.

Finance Lease Liability Interest Expense, Net

The increase in finance lease interest expense for the nine months ended September 30, 2024 is due to the addition of new capital lease during 2024.

Other (Income) Expense, Net

The increase in other (income) expense, net for the nine months ended September 30, 2024 is primarily due to California Department of Tax and Fee Administration "CDTFA" related penalties and fines that were incurred during the second and third quarter of 2024.

MANAGEMENT’S USE OF NON-GAAP FINANCIAL MEASURES

This MD&A contains certain financial performance measures, including “EBITDA” and “Adjusted EBITDA, that are not recognized under GAAP and do not have a standardized meaning prescribed by GAAP. As a result, these measures may not be comparable to similar measures presented by other companies. For a reconciliation of these measures to the most directly comparable financial information presented in the Financial Statements in accordance with GAAP, see the tables below for EBITDA and Adjusted EBITDA and the gross profit discussion section of the "Results of Operations" comparison of the fiscal quarters ended September 30, 2024 and 2023 of this MD&A.

EBITDA

We believe EBITDA is a useful measure to assess the performance of our Company as it provides more meaningful operating results by excluding the effects of expenses that are not reflective of our underlying business performance and other one-time or non-recurring expenses. We define EBITDA as net income (loss) before (i) depreciation and amortization; (ii) income taxes; and (iii) interest expense and debt amortization.

Adjusted EBITDA

We believe Adjusted EBITDA is a useful measure to assess the performance of our Company as it provides more meaningful operating results by excluding the effects of expenses that are not reflective of our underlying business performance and other one-time or non-recurring expenses. We define Adjusted EBITDA as EBITDA adjusted to exclude extraordinary items, non-recurring items and, other non-cash items, including, but not limited to (i) stock-based compensation expense, (ii) change in fair value of the earn out liability, (iii) non-recurring legal and professional fees, human-resources, inventory and collections-related expenses, (iv) intangible and goodwill

impairments and loss on disposal of assets, (v) transaction costs related to Business Combination and other acquisition activities, (vi) retail and cultivation pre-opening costs and, (vii) non-recurring inventory adjustments .


	Three months ended				Nine Months Ended
	September 30, 2024		September 30, 2023		September 30, 2024		September 30, 2023
Net Income (Loss)	$	(18,886)	$	22,960	$	(56,544)	$	(487)
Debt and Convertible Debt and Other Interest Expense, Net	1,705		3,181		3,631		6,329
Finance Lease Liability Interest Expense, Net	3,347		3,373		10,082		8,549
Amortization of Debt Discount Interest Expense, Net	444		278		800		1,495
Taxes	2,265		6,807		3,988		8,321
Depreciation and Amortization	4,886		5,465		12,985		10,197
EBITDA	$	(6,239)	$	42,064	$	(25,058)	$	34,404

Add back for Adjusted EBITDA
Non-cash Operating Lease Expense	$	(94)	$	333	$	(356)	$	625

Implementation Software Costs	—		—		110		—
Change in Fair Value of Earn Out Liability	—		—		—		4,375
Loss on Extinguishment of Debt	—		1,440		—		1,440
Gain on Bargain Purchase	—		(49,026)		—		(49,026)
Share-Based Compensation	87		469		366		567
Bad Debt Expense	296		5		707		328
Transaction Fees and Legal Fees	5,854		3,002		8,679		4,548
Penalties & Fines	2,755		—		8,332		—
Retail, Cultivation Preopening Costs and Other Non-Recurring	—		—		489		—
Non-Recurring inventory Adjustments	125		—		5,742		597
Adjusted EBITDA	$	2,784	$	(1,713)	$	(989)	$	(2,142)

EBITDA and Adjusted EBITDA

The decrease in EBITDA during the three and nine months ended September 30, 2024 is primarily due to a one time gain on bargain purchase price associated with the July 2023 merger.

The improvement in Adjusted EBITDA during the three months ended September 30, 2024 is mainly due to efficiencies achieved from the Company's vertical integration efforts since the July 2023 merger.

The decrease in both EBITDA and Adjusted EBITDA during the nine months ended September 30, 2024 is mainly due to the costs incurred following the Business Combination associated with improvement to overall operations as we implement efficiencies and focus on growing revenue streams. To some extent, the cultivation expansion has a non-recurring negative impact on earnings because each new flowering room has to undertake an eight-week grow cycle requiring labor and nutrients before the first harvest. An additional drying, curing and trimming is required prior to the first sale. These expenses stabilize once a normal weekly harvest cycle commences and will be spread across a broader inventory or COGS base.

LIQUIDITY AND CAPITAL RESOURCES

We are currently meeting our obligations as they become due from our current working capital and operations. Historically, our primary source of liquidity has been operations, capital contributions made by equity investors, debt issuances and most recently $55,629 of cash acquired as part of the Business Combination in July 2023. We believe that Gold Flora's efficient vertical-integration and increased scale will lead to longer-term profitability and sustainable cash flow.

As of September 30, 2024, we had cash and cash equivalents of approximately $10,166 compared to cash and cash equivalents of approximately $22,538 as of September 30, 2023.

We continue to evaluate additional opportunities for cost reductions and business optimizations to reduce cash use, accelerate profitable market share growth, improve gross margin profile and work toward generating sustained free cash flow over the longer term. We plan to raise additional capital as needed which if not available would raise substantial doubt about our ability to continue as a going concern.

If additional capital is required, we have access to public capital markets through our listing on the Cboe Canada exchange, and will continue to review and pursue selected external financing sources to ensure adequate financial resources. These potential sources include, but are not limited to (i) traditional or non-traditional investment capital organizations; (ii) sale of common stock or other equity or debt instruments; and (iii) debt financing with lending terms that more closely match our business model and capital needs. There can be no assurance that we will gain adequate market acceptance for our products or be able to generate sufficient positive cash flow to achieve its business plans, that additional capital or other types of financing will be available when needed, or that these financings will be on terms favorable to us or at all. In addition, due to the price of our common stock, raising equity capital currently may not be feasible. Any additional equity financing may be on terms that are dilutive, or potentially dilutive, to our shareholders and debt financing, if available, may involve restrictive covenants with respect to our ability to pay dividends, raise additional capital or execute various other financial and operational plans.

We do not have any requirements for capital expenditures. See "Note 14 - Commitments and Contingencies" above.

CASH FLOW ANALYSIS

Presented below is a summary of Gold Flora Corporation’s cash flows for the periods indicated:


	Nine Months Ended September 30,
	2024		2023



























Net cash used in operating activities	$	(5,786)	$	(24,821)







Net cash (provided by) used in investing activities	$	(2,050)	$	54,552












Net cash used in financing activities	$	(4,536)	$	(2,651)

Operating Activities

During the nine months ended September 30, 2024, the change in cash used in operating activities was due to the increased costs associated with operations of the larger amalgamated company following the Business Combination on July 7, 2023.

Investing Activities

During the nine months ended September 30, 2024, the change in cash used in investing activities was primarily due to the purchase of property and equipment and leasehold improvements for sustaining our operations.

Financing Activities

During the nine months ended September 30, 2024, the change in cash used in financing activities was primarily due to the debt repayment, while in the same period in the comparative quarter, we were a net issuer of debt.

CONTRACTUAL OBLIGATIONS

Lease Obligations, Notes Payable and Convertible Notes Payable

We have material lease obligations payable which are detailed in Note 8 of the interim condensed consolidated financial statements included in this Form 10-Q. We have material notes and convertible notes payable which are detailed in Notes 9 and 10 of the interim condensed consolidated financial statements included in this Form 10-Q.

COMMITMENTS AND CONTINGENCIES

California operating licenses

Our primary activity is engaging in state-legal commercial cannabis business, including the cultivation, manufacture, distribution, and sale of cannabis and cannabis products pursuant to California law. However, this activity is not in compliance with the United States Controlled Substances Act, or the CSA. Our assets are potentially subject to seizure or confiscation by Federal governmental agencies, and we could face criminal and civil penalties for noncompliance with the CSA, although such events would be without relevant precedent. Our management believes that we are in compliance with all California and local jurisdiction laws and monitors the regulatory environment on an ongoing basis along with counsel to ensure the continued compliance with all applicable laws and licensing agreements.

Our operation is sanctioned by the State of California and local jurisdictions. There have been no instances of federal interference with those who adhere to State of California and local laws and regulations regarding commercial cannabis activities. Due to the uncertainty surrounding our noncompliance with the CSA, the potential liability from any noncompliance cannot be reasonably estimated and we may be subject to regulatory fines, penalties or restrictions in the future.

Effective January 1, 2018, the State of California (the "State") allowed for adult use cannabis sales. Beginning on January 1, 2018, the State began issuing temporary licenses that expired 120 days after issuance for retail, distribution, manufacturing and cultivation permits. Temporary licenses could be extended in 90-day increments by the State upon submission of an annual license application. All temporary licenses had been granted extensions by the State during 2018.

In September 2019, Senate Bill 1459 (SB 1459) was enacted which enabled state licensing authorities to issue provisional licenses through 2021. A provisional license could be issued if an applicant submitted a completed annual license application to the Bureau of Cannabis Control. A completed application for purposes of obtaining a provisional license is not the same as a sufficient application to obtain an annual license. The provisional cannabis license, which is valid for 12 months from the date issued, is said to be in between a temporary license and an annual license and allows a cannabis business to operate as they would under local and state regulations.

Licensees issued a provisional license are expected to be diligently working toward completing all annual license requirements in order to maintain a provisional license. We obtained our provisional licenses in 2019 and continue to work with the State of California to obtain annual licensing.

Our prior licenses obtained from the local jurisdictions we operated in have been continued by such jurisdictions and are necessary to obtain State licensing.

We have received annual licenses from each local jurisdiction in which we actively operate. Although we believe we will continue to receive the necessary licenses from the State and applicable local jurisdictions to conduct our business in a timely fashion, there is no guarantee our clients will be able to do so and any failure of our clients to receive necessary licenses may have a negative effect on our business and results of operations.

Contingencies

Our operations are subject to a variety of local and state regulations. Failure to comply with one or more of those regulations could result in fines, restrictions on its operations, or losses of permits that could result in us ceasing operations in that specific state or local jurisdiction. While our management believes that we are in compliance with applicable local and state regulations, cannabis regulations continue to evolve and are subject to differing interpretations. As a result, we may be subject to regulatory fines, penalties, or restrictions in the future.

We have a loyalty program whereby customers accumulate points through purchases, and the earned points can be used to reduce the price of future purchases. The points do not expire and are recorded as a component of accounts payable and accrued liabilities on the accompanying condensed consolidated balance sheets for amounts customers have earned but have not yet used.

Claims and Litigation

On or about August 30, 2020, Gold Flora parties filed an action against Shelf Life, Inc. et al (“SLI”) in Orange County Superior Court in California, which actions was later submitted to binding arbitration pursuant to stipulation by the parties. In the action, Gold Flora disputed the amount of closing consideration owed to SLI following the acquisition of certain of its assets based on omission of relevant information, and SLI brought a cross-claim against Gold Flora seeking full payment of the $5.2 million note balance owed. The arbitrator in the matter issued an interim judgement awarding SLI $5.2 million, in addition to certain potential costs and interest. The arbitration was resolved on August 23, 2024 for a final judgment of $6.1 million.

On or about March 30, 2021, former directors and shareholders of LCV filed a complaint in Delaware Chancery Court against multiple defendant parties, including three former directors of LCV alleging breach of duties to the company and shareholders and other business torts and requesting monetary damages. Subsequently, plaintiffs filed a first amended complaint, adding new parties, including TPCO and a former TPCO director. We and LCV have certain indemnification obligations in connection with the defendant directors, which indemnification may be contested by LCV upon resolution of the action. We and LCV are subject to advancement actions brought with fees owed or claimed to be owed to counsel for the indemnified defendants as further described below.

Limited Receivership

On October 4, 2024, the Court of Chancery of the State of Delaware (the “Court”) granted an order advancing a motion for sanctions brought by the former directors (the “Order”) in Michael Auerbach v. Gold Flora Corporation (C.A. No. 2024-0225-MTZ) and Daniel Fireman, Christopher Akelman, Octavio Boccalandra v. Left Coast Ventures, Inc. (C.A. No. 2023-0588-MTZ). The Order held us and LCV in contempt for violation of advancement orders with respect to indemnification obligations for fees owed to counsel and related expenses, which amount is currently estimated at approximately $1.65 million.

Pursuant to the Order, the Court appointed Molly DiBianca of Clark Hill PLC (the “Limited Receiver”) as a limited purpose receiver to take such action that the Limited Receiver determines in good faith is appropriate to cause us and LCV to satisfy the amounts due under the Order, including accessing financial records and negotiation of a payment plan with the former directors (the “Charge”) pursuant to Title 8, Section 322 of the Delaware General Corporation Law (“Section 322”). The Order did not create a full, general receivership over us, and the Limited Receiver’s appointment is limited to the foregoing Charge. The Order provides that the Limited Receiver should first attempt to resort to resolving the Charge through operating cash flow. The Limited Receiver has all powers generally available to a receiver under Section 322 solely with respect to the Charge, and the Limited Receiver will not have authority over us except in connection with the Charge. The initial term for the Limited Receiver was 59 days from the date of the Order. Additionally, we and LCV would incur a daily fine of $1,000 until the contempt is cured, provided that the fine would not become due and payable if the Charge is satisfied or a payment plan is in place by October 31, 2024.

On November 4, 2024, the Court issued a stipulation and order (the “Stipulation”) and the Limited Receiver filed an interim report (the “Report”). The Stipulation requires us to pay an aggregate of $150,000 per month to the satisfy amounts due under the Order. Pursuant to the Report, the Limited Receiver stayed the limited receivership, conditioned upon our compliance with the payment plan and satisfaction of any future advancement demands brought by the former directors.

Inflation

We are not immune to the widespread cost inflation experienced in the United States and many parts of the world. We intend to continue to work to improve our gross margins despite cost inflation through market pricing, greater cost efficiencies, advantageous vendor partnerships, and other measures.

OFF-BALANCE SHEET ARRANGEMENTS

As of the date hereof, we do not have any off-balance sheet financing arrangements and have not guaranteed any debt or commitments of other entities or entered into any options on non-financial assets.

SHARE CAPITAL AND CAPITAL MANAGEMENT

As of September 30, 2024, we had 287,644,766 shares of common stock, 69,701,256 common stock purchase warrants and 13,753,065 stock options issued and outstanding. 35,837,500 warrants were assumed as part of the Business Combination in July 2023 and are exercisable at an exercise price of $6.47. Additionally, as of September 30, 2024, 33,863,756 warrants that were previously issued and outstanding as Gold Flora, LLC warrants and that were exchanged in the Business Combination for warrants of the Company have a weighted average exercise price of $1.05. As at September 30, 2024, the weighted average remaining term of all the warrants was 1.20 years.

No stock options were granted during the three months ended September 30, 2024. 13,657,500 stock options remain outstanding as of September 30, 2024. As of September 30, 2024, a total of 104,757 restricted stock units were outstanding under the former equity incentive plan of TPCO which was assumed in the July 2023 Business Combination.

We manage our capital with the following objectives:

•To ensure sufficient financial flexibility to achieve the ongoing business objectives including of future growth opportunities, and pursuit of accretive acquisitions; and

•To maximize shareholder return through enhancing the share value.

We consider our capital to be total equity. We manage capital through our financial and operational forecasting processes. We review our working capital and forecasts our future cash flows based on operating expenditures, and other investing and financing activities. Our capital management objectives, policies and processes have remained unchanged during the three months ended September 30, 2024 and year ended December 31, 2023. We are not subject to any external capital requirements.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

The preparation of consolidated financial statements in conformity with GAAP requires our management to make judgments, estimates and assumptions about future events that affect the amounts reported in the consolidated financial statements. Although these estimates are based on management’s best knowledge of the amount, event or actions, actual results may differ from those estimates. Estimates and judgments are continuously evaluated and are based on management’s experience and other factors, including expectations of future events that management considers to be reasonable.

Revisions to accounting estimates are recognized in the period in which the estimates are revised and in any future periods affected.

Consolidation

Judgment is applied in assessing whether the Company exercises control and has significant influence over entities in which the Company directly or indirectly owns an interest. The Company has control when it has the power over the subsidiary, has exposure or rights to variable returns, and has the ability to use its power to affect the returns. Significant influence is defined as the power to participate in the financial and operating decisions of the subsidiaries. Where the Company is determined to have control, these entities are consolidated. Additionally, judgment is applied in determining the effective date on which control was obtained.

Business combinations

Business combinations are accounted for using the acquisition method. The consideration transferred in a business combination is measured at fair value at the date of acquisition. Acquisition-related transaction costs are expensed as incurred. Identifiable assets and liabilities, including intangible assets, of acquired businesses are recorded at their fair value at the date of acquisition. When the Company acquires control of a business, any previously held equity interest also is remeasured to fair value. The excess of the purchase consideration and any previously held equity interest over the fair value of identifiable net assets acquired is goodwill. If the fair value of identifiable net assets acquired exceeds the purchase consideration and any previously held equity interest, the difference is recognized in the Consolidated Statements of Operations immediately as a gain or loss on acquisition.

Contingent consideration is measured at its acquisition-date fair value and included as part of the consideration transferred in a business combination. Contingent consideration that is classified as equity is not remeasured at subsequent reporting dates and its subsequent settlement is accounted for within equity. Contingent consideration that is classified as an asset or a liability is remeasured at subsequent reporting dates in accordance with ASC 450, Contingencies, as appropriate, with the corresponding gain or loss being recognized in profit or loss.

Leases

The Company accounts for its leases in accordance with ASU 2016-02, “Leases (Topic 842)” (“ASC 842”). In addition, the Company elected accounting policy elections to exclude from the consolidated balances the right-of-use (“ROU”) assets and lease liabilities related to short-term leases, which are those leases with a lease term of twelve months or less that do not include an option purchase the underlying lease asset that the Company is reasonably certain to exercise and to not separate leases and non-lease components. The Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease ROU assets and accrued obligations under operating lease (current and non-current) liabilities in the Consolidated Balance Sheets. Finance lease ROU assets are included in property and equipment, net and finance lease obligations are included under finance lease (current and non-

current) liabilities in the Consolidated Balance Sheets. Leases with an initial term of 12 months or less are not recorded on the Consolidated Balance Sheets and are expensed in the Consolidated Statements of Operations on the straight-line basis over the lease term.

ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. ROU assets are classified as a finance lease or an operating lease. A finance lease is a lease in which 1) ownership of the property transfers to the lessee by the end of the lease term; 2) the lease grants the lessee an option to purchase the underlying asset that the lessee is reasonably certain to exercise; 3) the lease is for a major part of the remaining economic life of the underlying asset; or 4) the present value of the sum of the lease payments and any residual value guaranteed by the lessee that is not already included in the lease payments equals or exceeds substantially all of the fair value; or 5) the underlying asset is of such a specialized nature that it is expected to have no alternative use to the lessor at the end of the lease term. The Company classifies a lease as an operating lease when it does not meet any one of these criteria.

The Company applies judgment in determining whether a contract contains a lease and if a lease is classified as an operating lease or a finance lease. The Company applies judgement in determining the lease term as the non-cancellable term of the lease, which may include options to extend or terminate the lease when it is reasonably certain that Gold Flora will exercise that option. All relevant factors that create an economic incentive for it to exercise either the renewal or termination are considered. The Company reassesses the lease term if there is a significant event or change in circumstances that is within its control and affects its ability to exercise or not to exercise the option to renew or to terminate. It considers whether the Company can benefit from the ROU asset either on its own or together with other resources and whether the asset is highly dependent on or highly interrelated with another ROU asset.

Convertible Notes Payable

The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with ASC 815, “Accounting for Derivative Instruments and Hedging Activities” (“ASC 815”). ASC 815 generally provide three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not remeasured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. Professional standards also provide an exception to this rule when the embedded features meet the criteria of contracts in an entity’s own equity in ASC 815-40. Gold Flora’s convertible notes payable met the exception described above.

The Company accounts for convertible instruments (when it has determined that the embedded conversion options should not be bifurcated from their host instruments) in accordance ASC 470, “Accounting for Convertible Securities with Beneficial Conversion Features”, as those professional standards pertain to “Certain Convertible Instruments”. Accordingly, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their earliest date of redemption. The Company also records when necessary deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. ASC 815 provides that generally, if an event that is not within the entity’s control could or require net cash settlement, then the contract shall be classified as an asset or a liability.

Goodwill

Goodwill is tested for impairment annually and whenever events or changes in circumstances indicate that the carrying amount of goodwill may have been impaired. In order to determine that the value of goodwill may have been impaired, we perform a qualitative assessment to determine whether it is more-likely-than-not that the reporting unit’s fair value is less than its carrying value, indicating the potential for goodwill impairment. A number of factors, including historical results, business plans, forecasts and market data are used to determine the fair value of the reporting unit. Changes in the conditions for these judgments and estimates can significantly affect the assessed value of goodwill.

Long-lived assets

Depreciation and amortization of property and equipment, right-of-use assets and finite-lived intangible assets are dependent upon estimates of useful lives, which are determined through the exercise of judgment. The assessment of any impairment of these assets is dependent upon estimates of recoverable amounts that consider factors such as economic and market conditions and the useful lives of assets. We use judgment in: (i) assessing whether there are impairment triggers affecting long-lived assets, (ii) determining the asset groups and(iii) determining the recoverable amount and if necessary, estimating the fair value.

Fair value measurement

We use valuation techniques to determine the fair value of financial instruments (where active market quotes are not available) and non-financial assets. This involves developing estimates and assumptions consistent with how market participants would price the instrument. We base our assumptions on observable data as far as possible, but this is not always available. In that case, we use the best information available. Estimated fair values may vary from the actual prices that would be achieved in an arm’s length transaction at the reporting date.

Revenue Recognition

Revenue is recognized by Gold Flora in accordance with ASU 2014-09, Revenue from Contracts with Customers (Topic 606). Through application of the standard, Gold Flora recognizes revenue to depict the transfer of promised goods or services to the customer in an amount that reflects the consideration to which Gold Flora expects to be entitled in exchange for those goods or services.

In order to recognize revenue under ASU 2014-09, Gold Flora applies the following five (5) steps:

·Identify a customer along with a corresponding contract;

·Identify the performance obligation(s) in the contract to transfer goods or provide distinct services to a customer;

·Determine the transaction price Gold Flora expects to be entitled to in exchange for transferring promised goods or services to a customer;

·Allocate the transaction price to the performance obligation(s) in the contract; and

·Recognize revenue when or as Gold Flora satisfies the performance obligation(s).

Revenue is recognized upon the satisfaction of the performance obligation. Gold Flora satisfies its performance obligation and transfers control upon delivery and acceptance by the customer.

Unredeemed awards are recorded as deferred revenue. At the time customers redeem points, the redemption is recorded as an increase to revenue. Deferred revenue is included in other accrued expenses within accounts payable and accrued liabilities. The Company’s return policy conforms to the Medicinal and Adult-Use Cannabis Regulation and Safety Act (“MAUCRSA”), which was signed into law in September 2017 and creates the general framework for the regulation of commercial medicinal and adult-use cannabis in California.

Recent and Anticipated Changes to Critical Accounting Policies

None.

United States Regulatory Environment

On February 8, 2018, the Canadian Securities Administrators revised their previously released Staff Notice 51-352 (Revised) (Issuers with U.S. Marijuana-Related Activities) (“Staff Notice 51-352”), which provides specific disclosure expectations for Canadian issuers that currently have, or are in the process of developing, cannabis-related activities in the United States as permitted within a particular state’s regulatory framework. All issuers with U.S. cannabis-related activities are expected to clearly and prominently disclose certain prescribed information in prospectus filings and other required disclosure documents. As a result of our existing operations in California, we are required to provide disclosure pursuant to Staff Notice 51-352.

The required disclosure pursuant to Staff Notice 51-352 is incorporated by reference from “United States Regulatory Environment” under “Item 1. Business” and “Risk Factors” under “Item 1A. Risk Factors” from our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, as filed with the SEC and with the relevant Canadian securities regulatory authorities under its profile on SEDAR+.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

Not applicable.

ITEM 4. CONTROLS AND PROCEDURES.

Evaluation of Disclosure Controls and Procedures.

Based on an evaluation as of September 30, 2024, our management, including the Principal Executive Officer and Principal Financial Officer, has concluded that our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) were not effective to provide reasonable assurance because of a material weakness in our internal control over financial reporting described below.

Material Weakness

As reported in our Annual Report on Form 10-K for the year ended December 31, 2023, we and our independent registered public accounting firm identified control deficiencies in the design and operation of internal control over financial reporting that constituted a material weakness.

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected in a timely manner.

We did not design or maintain an effective control environment commensurate with financial reporting requirements. Specifically, we lacked a sufficient number of adequately skilled professionals to appropriately analyze, record and disclose accounting matters timely and accurately while maintaining appropriate segregation of duties.

The material weakness described above did not result in a material misstatement of the previously issued financial statements; however, it could result in a misstatement of our account balances or disclosures that would result in a material misstatement of our annual or interim financial statements that would not be prevented or detected.

Remediation Activities

We continue to work to fully remediate the material weakness and are taking steps to strengthen our internal control over financial reporting. We are taking appropriate and reasonable steps to remediate this material weakness through the implementation of appropriate segregation of duties, formalization of accounting policies and controls (including evidence of review and timeliness of completion) and retention of appropriate expertise for complex accounting transactions.

Management expects to continue to review and make necessary changes to the overall design of our internal control environment, as well as policies and procedures to improve the overall effectiveness of our internal control over financial reporting. The material weakness will not be considered remediated, however, until the applicable controls operate for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively.

Changes in Internal Control over Financial Reporting

Other than set forth above, there has been no change in our internal control over financial reporting during the quarter ended September 30, 2024, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II-OTHER INFORMATION

Item 1. Legal Proceedings.

From time to time, we may be subject to legal proceedings in the ordinary course of our business. For more information regarding our current material legal proceedings, please see Note 14 - Commitments and Contingencies, to our unaudited condensed consolidated financial statements in Item 1 of Part I of this Quarterly Report on Form 10-Q.

ITEM 1A. RISK FACTORS.

In addition to the information set forth in this report, you should carefully consider the risk factors discussed in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, each of which is incorporated herein by reference and which could materially affect our business, financial condition or future results. The risks described herein and in the Annual Report on Form 10-K for the fiscal year ended December 31, 2023 are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results. We do not believe that there have been any material changes from the risk factors previously disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023.

Item 2. Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities.

None

Item 3. Defaults Upon Senior Securities.

None

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

No officers or directors, as defined in Rule 16a-1(f), adopted, modified or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement as defined in item 408 of Regulation S-K, during the period ended September 30, 2024.

Item 6. Exhibits.


		Incorporated by Reference From
Exhibit No.	Title of Document	Form	Date Filed	Exhibit Number	Filed Herewith
4.1	Installment Note dated August 27, 2024	8-K	8/28/2024	4.1
10.1*	Loan Agreement by and between Gold Flora Corporation and J.J. Astor & Co.	8-K	8/28/2024	10.1
10.2	Pledge Agreement by and among Gold Flora Corporation, J.J. Astor & Co., and the Pledgors named therein	8-K	8/28/2024	10.2
10.3*	Registration Rights Agreement by and among Gold Flora Corporation and J.J. Astor & Co.	8-K	8/28/2024	10.3
31.1	Section 302 Certification of Principal Executive Officer	-	-	-	X
31.2	Section 302 Certification of Principal Financial Officer	-	-	-	X
32.1	Section 1350 Certification of Principal Executive Officer	-	-	-	X
32.2	Section 1350 Certification of Principal Financial Officer	-	-	-	X
101.SCH	Inline XBRL Taxonomy Extension Schema Document	-	-	-	X
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document	-	-	-	X
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document	-	-	-	X
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document	-	-	-	X
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document				X
104	Cover Page Interactive Data File (embedded within the Inline XBRL document)				X

* Schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The registrant hereby undertakes to furnish copies of any of the omitted schedules and exhibits upon request by the U.S. Securities and Exchange Commission.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


	GOLD FLORA CORPORATION

Date: November 14, 2024	By:	/s/ Laurie Holcomb
		Laurie Holcomb
		Chief Executive Officer
		(Principal Executive Officer)

Date: November 14, 2024	By:	/s/ Marshall Minor
		Marshall Minor
		Chief Financial Officer (Principal Financial Officer)

Get the next $GRAM alert in real time by email

SEC Form 10-Q filed by Grana y Montero S.A.A.

Chat with this insight

Recent Analyst Ratings for
$GRAM

$GRAM
Market Insights

Live Market Insights

Cannabis Chart Of The Week: Is Financial Strength Related To YTD Stock Performance?

Maintaining A Balanced Accounts Receivable Sheet In Cannabis: CEO Of Gold Flora Shares Her Secret

Latest Executive Cannabis Changes You Should Know About: Curaleaf, Planet 13 Elect Directors And More

$GRAM
SEC Filings

Grana y Montero S.A.A. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

Grana y Montero S.A.A. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits